TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-3000157	Laminin interactions	4.93568846913531e-05	-9.91643329439147	23	5	0.0333333333333333	150	8202	3910,3913,3675,3691,3912	LAMA4,LAMB2,ITGA3,ITGB4,LAMB1
R-HSA-556833	Metabolism of lipids and lipoproteins	0.000163415438891168	-8.71921489474375	628	25	0.166666666666667	150	8202	1591,10484,8760,5468,3635,27242,84803,7108,10162,79642,51129,1119,123,85441,51,2232,8821,5290,51495,8714,4048,37,204962,6576,3156	CYP24A1,SEC23A,CDS2,PPARG,INPP5D,TNFRSF21,GPAT3,TM7SF2,LPCAT3,ARSJ,ANGPTL4,CHKA,PLIN2,HELZ2,ACOX1,FDXR,INPP4B,PIK3CA,HACD3,ABCC3,LTA4H,ACADVL,SLC44A5,SLC25A1,HMGCR
R-HSA-1430728	Metabolism	0.000644521860755559	-7.34700181722224	1691	48	0.32	150	8202	1591,8760,4719,6819,3635,27242,57214,84803,6513,9123,10162,5720,51477,79642,79586,1119,85441,1890,3038,64428,2232,5290,2941,960,5631,204962,6576,3156,4907,516,10484,10678,5468,6303,7108,51129,123,847,50484,51,8821,5243,51495,8714,4048,66002,37,2582	CYP24A1,CDS2,NDUFS1,SULT1C2,INPP5D,TNFRSF21,CEMIP,GPAT3,SLC2A1,SLC16A3,LPCAT3,PSME1,ISYNA1,ARSJ,CHPF,CHKA,HELZ2,TYMP,HAS3,NARFL,FDXR,PIK3CA,GSTA4,CD44,PRPS1,SLC44A5,SLC25A1,HMGCR,NT5E,ATP5G1,SEC23A,B3GNT2,PPARG,SAT1,TM7SF2,ANGPTL4,PLIN2,CAT,RRM2B,ACOX1,INPP4B,ABCB1,HACD3,ABCC3,LTA4H,CYP4F12,ACADVL,GALE
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.00170504316804895	-6.37416485006338	212	11	0.0733333333333333	150	8202	123,85441,5468,27242,51,84803,51495,37,51129,6576,3156	PLIN2,HELZ2,PPARG,TNFRSF21,ACOX1,GPAT3,HACD3,ACADVL,ANGPTL4,SLC25A1,HMGCR
R-HSA-2142850	Hyaluronan biosynthesis and export	0.00320436246336293	-5.74324212778413	5	2	0.0133333333333333	150	8202	3038,57214	HAS3,CEMIP
R-HSA-2142845	Hyaluronan metabolism	0.00337737307813197	-5.6906570674794	17	3	0.02	150	8202	960,3038,57214	CD44,HAS3,CEMIP
R-HSA-1989781	PPARA activates gene expression	0.00434674925428573	-5.43832701111313	112	7	0.0466666666666667	150	8202	123,85441,5468,27242,51129,51,3156	PLIN2,HELZ2,PPARG,TNFRSF21,ANGPTL4,ACOX1,HMGCR
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.00489323374109817	-5.31990189730761	38	4	0.0266666666666667	150	8202	2934,7431,5588,4000	GSN,VIM,PRKCQ,LMNA
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.00502433773873052	-5.29346162700996	115	7	0.0466666666666667	150	8202	123,85441,5468,27242,51129,51,3156	PLIN2,HELZ2,PPARG,TNFRSF21,ANGPTL4,ACOX1,HMGCR
R-HSA-1483257	Phospholipid metabolism	0.00522350263009718	-5.25458710017441	146	8	0.0533333333333333	150	8202	8760,3635,84803,8821,5290,10162,204962,1119	CDS2,INPP5D,GPAT3,INPP4B,PIK3CA,LPCAT3,SLC44A5,CHKA
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.006569002577552	-5.02539327269069	7	2	0.0133333333333333	150	8202	81607,25945	PVRL4,PVRL3
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.00701374554834951	-4.95988340560262	42	4	0.0266666666666667	150	8202	3910,3913,3691,3912	LAMA4,LAMB2,ITGB4,LAMB1
R-HSA-109581	Apoptosis	0.00893510103791029	-4.71776782233056	160	8	0.0533333333333333	150	8202	2934,8737,5720,5588,7431,317,4000,2810	GSN,RIPK1,PSME1,PRKCQ,VIM,APAF1,LMNA,SFN
R-HSA-5365859	RA biosynthesis pathway	0.00915617402376681	-4.69332687054483	24	3	0.02	150	8202	9249,220,157506	DHRS3,ALDH1A3,RDH10
R-HSA-5357801	Programmed Cell Death	0.0099377711218689	-4.61141251667006	163	8	0.0533333333333333	150	8202	2934,8737,5720,5588,7431,317,4000,2810	GSN,RIPK1,PSME1,PRKCQ,VIM,APAF1,LMNA,SFN
R-HSA-446107	Type I hemidesmosome assembly	0.0109939000898704	-4.51041469728094	9	2	0.0133333333333333	150	8202	1308,3691	COL17A1,ITGB4
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.0114533557522305	-4.46947251312366	26	3	0.02	150	8202	8737,23220,1660	RIPK1,DTX4,DHX9
R-HSA-74259	Purine catabolism	0.0135786914682461	-4.29925351876626	10	2	0.0133333333333333	150	8202	847,4907	CAT,NT5E
R-HSA-75153	Apoptotic execution  phase	0.0147458824223782	-4.21679139297297	52	4	0.0266666666666667	150	8202	2934,7431,5588,4000	GSN,VIM,PRKCQ,LMNA
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.0163987953430599	-4.11054740154138	11	2	0.0133333333333333	150	8202	51477,8821	ISYNA1,INPP4B
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.0167512547456247	-4.08928211333014	54	4	0.0266666666666667	150	8202	7108,10484,85441,3156	TM7SF2,SEC23A,HELZ2,HMGCR
R-HSA-399719	Trafficking of AMPA receptors	0.0169613310817798	-4.07681916810255	30	3	0.02	150	8202	817,4193,160	CAMK2D,MDM2,AP2A1
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.0169613310817798	-4.07681916810255	30	3	0.02	150	8202	182,92737,23220	JAG1,DNER,DTX4
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.0169613310817798	-4.07681916810255	30	3	0.02	150	8202	817,4193,160	CAMK2D,MDM2,AP2A1
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.0194448587070794	-3.94017257768628	12	2	0.0133333333333333	150	8202	2934,7431	GSN,VIM
R-HSA-73621	Pyrimidine catabolism	0.0194448587070794	-3.94017257768628	12	2	0.0133333333333333	150	8202	1890,4907	TYMP,NT5E
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.019477680812019	-3.93848604267982	85	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.0219075913993406	-3.82092206298589	33	3	0.02	150	8202	3635,8821,5290	INPP5D,INPP4B,PIK3CA
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.0227077879870195	-3.78504733020573	13	2	0.0133333333333333	150	8202	4193,1026	MDM2,CDKN1A
R-HSA-418555	G alpha (s) signalling events	0.0287304210840828	-3.54979874949957	127	6	0.04	150	8202	7433,136,10846,133,5139,5142	VIPR1,ADORA2B,PDE10A,ADM,PDE3A,PDE4B
R-HSA-2682334	EPH-Ephrin signaling	0.0298038911348069	-3.51311631900143	95	5	0.0333333333333333	150	8202	1948,6386,7074,160,9475	EFNB2,SDCBP,TIAM1,AP2A1,ROCK2
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.0298491297750076	-3.51159959283457	15	2	0.0133333333333333	150	8202	1956,5290	EGFR,PIK3CA
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.0298491297750076	-3.51159959283457	15	2	0.0133333333333333	150	8202	1956,5290	EGFR,PIK3CA
R-HSA-1483206	Glycerophospholipid biosynthesis	0.0309944709954665	-3.47394644538909	96	5	0.0333333333333333	150	8202	10162,8760,84803,204962,1119	LPCAT3,CDS2,GPAT3,SLC44A5,CHKA
R-HSA-373760	L1CAM interactions	0.0322145921634527	-3.43533575630551	97	5	0.0333333333333333	150	8202	6386,214,160,3912,1956	SDCBP,ALCAM,AP2A1,LAMB1,EGFR
R-HSA-1250342	PI3K events in ERBB4 signaling	0.033464424614027	-3.39727235624156	98	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-5654720	PI-3K cascade:FGFR4	0.033464424614027	-3.39727235624156	98	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-5654689	PI-3K cascade:FGFR1	0.033464424614027	-3.39727235624156	98	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-5654695	PI-3K cascade:FGFR2	0.033464424614027	-3.39727235624156	98	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-5654710	PI-3K cascade:FGFR3	0.033464424614027	-3.39727235624156	98	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-1257604	PIP3 activates AKT signaling	0.033464424614027	-3.39727235624156	98	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-1963642	PI3K events in ERBB2 signaling	0.033464424614027	-3.39727235624156	98	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-1266738	Developmental Biology	0.0338173102974243	-3.38678246861452	710	20	0.133333333333333	150	8202	1948,2254,5468,5087,5588,5720,214,51129,1956,85441,817,2905,160,3912,6386,7026,7414,10371,7074,9475	EFNB2,FGF9,PPARG,PBX1,PRKCQ,PSME1,ALCAM,ANGPTL4,EGFR,HELZ2,CAMK2D,GRIN2C,AP2A1,LAMB1,SDCBP,NR2F2,VCL,SEMA3A,TIAM1,ROCK2
R-HSA-202733	Cell surface interactions at the vascular wall	0.0347441273267036	-3.35974471904578	99	5	0.0333333333333333	150	8202	3675,960,3635,9123,5290	ITGA3,CD44,INPP5D,SLC16A3,PIK3CA
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.036244174906599	-3.31747660282558	2	1	0.00666666666666667	150	8202	3304	HSPA1B
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.036244174906599	-3.31747660282558	2	1	0.00666666666666667	150	8202	1026	CDKN1A
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.036244174906599	-3.31747660282558	2	1	0.00666666666666667	150	8202	1956	EGFR
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.036244174906599	-3.31747660282558	2	1	0.00666666666666667	150	8202	1026	CDKN1A
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.036244174906599	-3.31747660282558	2	1	0.00666666666666667	150	8202	1956	EGFR
R-HSA-198203	PI3K/AKT activation	0.0373937244472813	-3.28625238416813	101	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.03775502650566	-3.27663665968329	17	2	0.0133333333333333	150	8202	817,2905	CAMK2D,GRIN2C
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.03775502650566	-3.27663665968329	17	2	0.0133333333333333	150	8202	817,2905	CAMK2D,GRIN2C
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.038531081035652	-3.25629006375214	41	3	0.02	150	8202	7108,85441,3156	TM7SF2,HELZ2,HMGCR
R-HSA-180292	GAB1 signalosome	0.0387638817949379	-3.250266347466	102	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-3928662	EPHB-mediated forward signaling	0.0409554914579388	-3.1952693761369	42	3	0.02	150	8202	1948,7074,9475	EFNB2,TIAM1,ROCK2
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.0415954889747492	-3.17976355570175	104	5	0.0333333333333333	150	8202	2254,4193,1026,1956,5290	FGF9,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-418457	cGMP effects	0.0419745317064269	-3.17069223256851	18	2	0.0133333333333333	150	8202	10846,5139	PDE10A,PDE3A
R-HSA-1980143	Signaling by NOTCH1	0.0424526647236037	-3.15936559496517	72	4	0.0266666666666667	150	8202	7088,182,92737,23220	TLE1,JAG1,DNER,DTX4
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.0442988720698043	-3.11679606343342	73	4	0.0266666666666667	150	8202	143686,27244,50484,2810	SESN3,SESN1,RRM2B,SFN
R-HSA-3700989	Transcriptional Regulation by TP53	0.0442988720698043	-3.11679606343342	73	4	0.0266666666666667	150	8202	143686,27244,50484,2810	SESN3,SESN1,RRM2B,SFN
R-HSA-5362517	Signaling by Retinoic Acid	0.0460297407004422	-3.07846755444189	44	3	0.02	150	8202	9249,220,157506	DHRS3,ALDH1A3,RDH10
R-HSA-382556	ABC-family proteins mediated transport	0.0460297407004422	-3.07846755444189	44	3	0.02	150	8202	8714,5825,5243	ABCC3,ABCD3,ABCB1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.0463614487063923	-3.07128701193946	19	2	0.0133333333333333	150	8202	1956,5290	EGFR,PIK3CA
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.0463614487063923	-3.07128701193946	19	2	0.0133333333333333	150	8202	817,2905	CAMK2D,GRIN2C
R-HSA-3928664	Ephrin signaling	0.0463614487063923	-3.07128701193946	19	2	0.0133333333333333	150	8202	1948,6386	EFNB2,SDCBP
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.0463614487063923	-3.07128701193946	19	2	0.0133333333333333	150	8202	1956,5290	EGFR,PIK3CA
R-HSA-1643713	Signaling by EGFR in Cancer	0.0463614487063923	-3.07128701193946	19	2	0.0133333333333333	150	8202	1956,5290	EGFR,PIK3CA
R-HSA-446203	Asparagine N-linked glycosylation	0.048017471998294	-3.0361903343417	181	7	0.0466666666666667	150	8202	2517,10484,26503,85365,29926,7039,4121	FUCA1,SEC23A,SLC17A5,ALG2,GMPPA,TGFA,MAN1A1
R-HSA-422475	Axon guidance	0.0498191502081268	-2.99935582653712	516	15	0.1	150	8202	1948,2254,817,2905,160,3912,5720,5588,6386,7414,214,7074,10371,9475,1956	EFNB2,FGF9,CAMK2D,GRIN2C,AP2A1,LAMB1,PSME1,PRKCQ,SDCBP,VCL,ALCAM,TIAM1,SEMA3A,ROCK2,EGFR
R-HSA-1483191	Synthesis of PC	0.0509083323788562	-2.97772866786335	20	2	0.0133333333333333	150	8202	204962,1119	SLC44A5,CHKA
R-HSA-1483249	Inositol phosphate metabolism	0.0513999212754641	-2.96811863812795	46	3	0.02	150	8202	51477,3635,8821	ISYNA1,INPP5D,INPP4B
R-HSA-5653890	Lactose synthesis	0.053873854634507	-2.92110999046854	3	1	0.00666666666666667	150	8202	6513	SLC2A1
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.053873854634507	-2.92110999046854	3	1	0.00666666666666667	150	8202	4121	MAN1A1
R-HSA-111458	Formation of apoptosome	0.053873854634507	-2.92110999046854	3	1	0.00666666666666667	150	8202	317	APAF1
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.053873854634507	-2.92110999046854	3	1	0.00666666666666667	150	8202	5631	PRPS1
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.053873854634507	-2.92110999046854	3	1	0.00666666666666667	150	8202	2232	FDXR
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.053873854634507	-2.92110999046854	3	1	0.00666666666666667	150	8202	37	ACADVL
R-HSA-352238	Breakdown of the nuclear lamina	0.053873854634507	-2.92110999046854	3	1	0.00666666666666667	150	8202	4000	LMNA
R-HSA-351200	Interconversion of polyamines	0.053873854634507	-2.92110999046854	3	1	0.00666666666666667	150	8202	6303	SAT1
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.0541967202200075	-2.91513488491348	78	4	0.0266666666666667	150	8202	85441,7026,5468,51129	HELZ2,NR2F2,PPARG,ANGPTL4
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.0556079507260402	-2.88942908927915	21	2	0.0133333333333333	150	8202	8737,1660	RIPK1,DHX9
R-HSA-1474244	Extracellular matrix organization	0.055889557315292	-2.88437772637437	267	9	0.06	150	8202	3910,650,1308,3675,3912,3913,960,3691,4325	LAMA4,BMP2,COL17A1,ITGA3,LAMB1,LAMB2,CD44,ITGB4,MMP16
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.0570597754673201	-2.86365586823221	48	3	0.02	150	8202	1948,7074,160	EFNB2,TIAM1,AP2A1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0596778826512203	-2.81879380208028	312	10	0.0666666666666667	150	8202	2254,817,1535,2905,5290,5720,7414,9564,9475,1956	FGF9,CAMK2D,CYBA,GRIN2C,PIK3CA,PSME1,VCL,BCAR1,ROCK2,EGFR
R-HSA-5655332	Signaling by FGFR3 in disease	0.0604532796418286	-2.80588444959933	22	2	0.0133333333333333	150	8202	2254,5290	FGF9,PIK3CA
R-HSA-3371571	HSF1-dependent transactivation	0.0604532796418286	-2.80588444959933	22	2	0.0133333333333333	150	8202	817,3304	CAMK2D,HSPA1B
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.060665105218488	-2.80238661906147	81	4	0.0266666666666667	150	8202	8737,10010,3659,1660	RIPK1,TANK,IRF1,DHX9
R-HSA-15869	Metabolism of nucleotides	0.0629085714567278	-2.76607285338767	82	4	0.0266666666666667	150	8202	847,1890,50484,4907	CAT,TYMP,RRM2B,NT5E
R-HSA-71387	Metabolism of carbohydrates	0.0636976387346514	-2.75360778562088	274	9	0.06	150	8202	10678,3038,57214,6513,960,5631,6576,2582,79586	B3GNT2,HAS3,CEMIP,SLC2A1,CD44,PRPS1,SLC25A1,GALE,CHPF
R-HSA-191273	Cholesterol biosynthesis	0.0654374978343991	-2.72665982344557	23	2	0.0133333333333333	150	8202	7108,3156	TM7SF2,HMGCR
R-HSA-1483255	PI Metabolism	0.0660772894343416	-2.71693017006682	51	3	0.02	150	8202	3635,8821,5290	INPP5D,INPP4B,PIK3CA
R-HSA-194138	Signaling by VEGF	0.0683182019008656	-2.68357904862941	320	10	0.0666666666666667	150	8202	2254,817,1535,2905,5290,5720,7414,9564,9475,1956	FGF9,CAMK2D,CYBA,GRIN2C,PIK3CA,PSME1,VCL,BCAR1,ROCK2,EGFR
R-HSA-912526	Interleukin receptor SHC signaling	0.0701666893627995	-2.65688159106754	238	8	0.0533333333333333	150	8202	2254,817,2905,3635,5290,5720,7414,1956	FGF9,CAMK2D,GRIN2C,INPP5D,PIK3CA,PSME1,VCL,EGFR
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.0705539818165205	-2.65137716263713	24	2	0.0133333333333333	150	8202	4193,1026	MDM2,CDKN1A
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.0705539818165205	-2.65137716263713	24	2	0.0133333333333333	150	8202	10484,6892	SEC23A,TAPBP
R-HSA-73848	Pyrimidine metabolism	0.0705539818165205	-2.65137716263713	24	2	0.0133333333333333	150	8202	1890,4907	TYMP,NT5E
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.0705539818165205	-2.65137716263713	24	2	0.0133333333333333	150	8202	10846,5139	PDE10A,PDE3A
R-HSA-186763	Downstream signal transduction	0.0705973787149163	-2.65076226385613	322	10	0.0666666666666667	150	8202	2254,817,4193,2905,5290,5720,1026,7414,9564,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,BCAR1,EGFR
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.0711831511106622	-2.64249913027246	4	1	0.00666666666666667	150	8202	2232	FDXR
R-HSA-417973	Adenosine P1 receptors	0.0711831511106622	-2.64249913027246	4	1	0.00666666666666667	150	8202	136	ADORA2B
R-HSA-433692	Proton-coupled monocarboxylate transport	0.0711831511106622	-2.64249913027246	4	1	0.00666666666666667	150	8202	9123	SLC16A3
R-HSA-446728	Cell junction organization	0.0723132498785919	-2.62674790411012	86	4	0.0266666666666667	150	8202	81607,1308,3691,25945	PVRL4,COL17A1,ITGB4,PVRL3
R-HSA-381038	XBP1(S) activates chaperone genes	0.0724295250222179	-2.62514125854571	53	3	0.02	150	8202	37,4189,4000	ACADVL,DNAJB9,LMNA
R-HSA-1630316	Glycosaminoglycan metabolism	0.0746402535668306	-2.5950753252512	123	5	0.0333333333333333	150	8202	10678,960,3038,57214,79586	B3GNT2,CD44,HAS3,CEMIP,CHPF
R-HSA-210991	Basigin interactions	0.0757963010480631	-2.57970578636273	25	2	0.0133333333333333	150	8202	3675,9123	ITGA3,SLC16A3
R-HSA-381070	IRE1alpha activates chaperones	0.079044517540451	-2.53774407205877	55	3	0.02	150	8202	37,4189,4000	ACADVL,DNAJB9,LMNA
R-HSA-1474228	Degradation of the extracellular matrix	0.0798115583445553	-2.52808694360441	89	4	0.0266666666666667	150	8202	1308,960,4325,3912	COL17A1,CD44,MMP16,LAMB1
R-HSA-451927	Interleukin-2 signaling	0.0799943534811458	-2.52579922828492	245	8	0.0533333333333333	150	8202	2254,817,2905,3635,5290,5720,7414,1956	FGF9,CAMK2D,GRIN2C,INPP5D,PIK3CA,PSME1,VCL,EGFR
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.0811582131556577	-2.51135478058456	26	2	0.0133333333333333	150	8202	51384,79971	WNT16,WLS
R-HSA-3000178	ECM proteoglycans	0.0824478123419849	-2.49558976347608	56	3	0.02	150	8202	3910,3913,3912	LAMA4,LAMB2,LAMB1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.0859134657560298	-2.45441470143909	57	3	0.02	150	8202	5720,4193,1026	PSME1,MDM2,CDKN1A
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.0859134657560298	-2.45441470143909	57	3	0.02	150	8202	5720,4193,1026	PSME1,MDM2,CDKN1A
R-HSA-182971	EGFR downregulation	0.086633659291732	-2.44606686350432	27	2	0.0133333333333333	150	8202	160,1956	AP2A1,EGFR
R-HSA-5655253	Signaling by FGFR2 in disease	0.086633659291732	-2.44606686350432	27	2	0.0133333333333333	150	8202	2254,5290	FGF9,PIK3CA
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.0873949902383956	-2.43731731789032	168	6	0.04	150	8202	2254,5720,4193,1026,1956,5290	FGF9,PSME1,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-877300	Interferon gamma signaling	0.0876816583390288	-2.4340425424231	92	4	0.0266666666666667	150	8202	817,4940,960,3659	CAMK2D,OAS3,CD44,IRF1
R-HSA-177929	Signaling by EGFR	0.087902434427621	-2.43152777925221	336	10	0.0666666666666667	150	8202	2254,817,4193,2905,160,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,AP2A1,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-109582	Hemostasis	0.0879996550648001	-2.43042238422979	515	14	0.0933333333333333	150	8202	3675,6281,10846,3635,9123,5290,5588,50808,960,9564,7414,5139,3659,2152	ITGA3,S100A10,PDE10A,INPP5D,SLC16A3,PIK3CA,PRKCQ,AK3,CD44,BCAR1,VCL,PDE3A,IRF1,F3
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.0881778482736157	-2.42839950087405	5	1	0.00666666666666667	150	8202	2152	F3
R-HSA-446205	Synthesis of GDP-mannose	0.0881778482736157	-2.42839950087405	5	1	0.00666666666666667	150	8202	29926	GMPPA
R-HSA-2161517	Abacavir transmembrane transport	0.0881778482736157	-2.42839950087405	5	1	0.00666666666666667	150	8202	5243	ABCB1
R-HSA-70370	Galactose catabolism	0.0881778482736157	-2.42839950087405	5	1	0.00666666666666667	150	8202	2582	GALE
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.0881778482736157	-2.42839950087405	5	1	0.00666666666666667	150	8202	60489	APOBEC3G
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.0881778482736157	-2.42839950087405	5	1	0.00666666666666667	150	8202	317	APAF1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.0881778482736157	-2.42839950087405	5	1	0.00666666666666667	150	8202	4121	MAN1A1
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.0881778482736157	-2.42839950087405	5	1	0.00666666666666667	150	8202	317	APAF1
R-HSA-1500931	Cell-Cell communication	0.0918519790544922	-2.38757692096094	131	5	0.0333333333333333	150	8202	81607,1308,3691,25945,5290	PVRL4,COL17A1,ITGB4,PVRL3,PIK3CA
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.0937831027347406	-2.36677058061805	254	8	0.0533333333333333	150	8202	2254,817,2905,3635,5290,5720,7414,1956	FGF9,CAMK2D,GRIN2C,INPP5D,PIK3CA,PSME1,VCL,EGFR
R-HSA-948021	Transport to the Golgi and subsequent modification	0.0959136920023146	-2.34430653353718	95	4	0.0266666666666667	150	8202	2517,10484,7039,4121	FUCA1,SEC23A,TGFA,MAN1A1
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.0960463528501228	-2.3429243618563	342	10	0.0666666666666667	150	8202	2254,817,4193,2905,5290,5588,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PRKCQ,PSME1,CDKN1A,VCL,EGFR
R-HSA-69615	G1/S DNA Damage Checkpoints	0.0966729136647638	-2.33642202263953	60	3	0.02	150	8202	5720,4193,1026	PSME1,MDM2,CDKN1A
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.097901808656802	-2.32379025508311	29	2	0.0133333333333333	150	8202	85441,860	HELZ2,RUNX2
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.097901808656802	-2.32379025508311	29	2	0.0133333333333333	150	8202	817,2905	CAMK2D,GRIN2C
R-HSA-1839124	FGFR1 mutant receptor activation	0.097901808656802	-2.32379025508311	29	2	0.0133333333333333	150	8202	2254,5290	FGF9,PIK3CA
R-HSA-202424	Downstream TCR signaling	0.0987362668294005	-2.31530295495407	96	4	0.0266666666666667	150	8202	5588,5720,3635,5290	PRKCQ,PSME1,INPP5D,PIK3CA
R-HSA-186797	Signaling by PDGF	0.100281994303124	-2.29976911854313	345	10	0.0666666666666667	150	8202	2254,817,4193,2905,5290,5720,1026,7414,9564,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,BCAR1,EGFR
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.100376248983368	-2.29882966362084	61	3	0.02	150	8202	2254,1956,5290	FGF9,EGFR,PIK3CA
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.100376248983368	-2.29882966362084	61	3	0.02	150	8202	1591,66002,2232	CYP24A1,CYP4F12,FDXR
R-HSA-2559585	Oncogene Induced Senescence	0.103683271339998	-2.26641449459972	30	2	0.0133333333333333	150	8202	4193,3397	MDM2,ID1
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.104863626330726	-2.25509456984248	6	1	0.00666666666666667	150	8202	51	ACOX1
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.104863626330726	-2.25509456984248	6	1	0.00666666666666667	150	8202	2517	FUCA1
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.104863626330726	-2.25509456984248	6	1	0.00666666666666667	150	8202	2232	FDXR
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.104863626330726	-2.25509456984248	6	1	0.00666666666666667	150	8202	23220	DTX4
R-HSA-211916	Vitamins	0.104863626330726	-2.25509456984248	6	1	0.00666666666666667	150	8202	1591	CYP24A1
R-HSA-1433557	Signaling by SCF-KIT	0.109549099115236	-2.21138243647757	307	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-418990	Adherens junctions interactions	0.109555778374727	-2.21132146787139	31	2	0.0133333333333333	150	8202	81607,25945	PVRL4,PVRL3
R-HSA-69620	Cell Cycle Checkpoints	0.109786867927322	-2.20921435699266	179	6	0.04	150	8202	51434,5720,4193,672,1026,2810	ANAPC7,PSME1,MDM2,BRCA1,CDKN1A,SFN
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.113418687938021	-2.17666910463438	101	4	0.0266666666666667	150	8202	30061,204962,6513,9123	SLC40A1,SLC44A5,SLC2A1,SLC16A3
R-HSA-5654716	Downstream signaling of activated FGFR4	0.114457619618637	-2.16755065883951	310	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654687	Downstream signaling of activated FGFR1	0.114457619618637	-2.16755065883951	310	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654708	Downstream signaling of activated FGFR3	0.114457619618637	-2.16755065883951	310	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654696	Downstream signaling of activated FGFR2	0.114457619618637	-2.16755065883951	310	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.115184197003539	-2.16122271891894	355	10	0.0666666666666667	150	8202	2254,817,4193,2905,160,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,AP2A1,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-397014	Muscle contraction	0.115741180680673	-2.15639878174217	65	3	0.02	150	8202	7431,7414,301	VIM,VCL,ANXA1
R-HSA-5663202	Diseases of signal transduction	0.117781928899602	-2.13892042445937	268	8	0.0533333333333333	150	8202	2254,182,4193,5290,54894,5720,1026,1956	FGF9,JAG1,MDM2,PIK3CA,RNF43,PSME1,CDKN1A,EGFR
R-HSA-1236394	Signaling by ERBB4	0.117797251444349	-2.13879034042778	312	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654741	Signaling by FGFR3	0.119487141586691	-2.12454651518507	313	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654743	Signaling by FGFR4	0.119487141586691	-2.12454651518507	313	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.119714058762777	-2.12264922333349	66	3	0.02	150	8202	8737,23220,1660	RIPK1,DTX4,DHX9
R-HSA-5654736	Signaling by FGFR1	0.121190361109269	-2.11039273731091	314	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.121246063627092	-2.10993321462275	7	1	0.00666666666666667	150	8202	160	AP2A1
R-HSA-447043	Neurofascin interactions	0.121246063627092	-2.10993321462275	7	1	0.00666666666666667	150	8202	6386	SDCBP
R-HSA-111471	Apoptotic factor-mediated response	0.121246063627092	-2.10993321462275	7	1	0.00666666666666667	150	8202	317	APAF1
R-HSA-196791	Vitamin D (calciferol) metabolism	0.121246063627092	-2.10993321462275	7	1	0.00666666666666667	150	8202	1591	CYP24A1
R-HSA-190371	FGFR3b ligand binding and activation	0.121246063627092	-2.10993321462275	7	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.121246063627092	-2.10993321462275	7	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.121246063627092	-2.10993321462275	7	1	0.00666666666666667	150	8202	9249	DHRS3
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.121246063627092	-2.10993321462275	7	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-73847	Purine metabolism	0.121553253306549	-2.10740281340707	33	2	0.0133333333333333	150	8202	847,4907	CAT,NT5E
R-HSA-933541	TRAF6 mediated IRF7 activation	0.121553253306549	-2.10740281340707	33	2	0.0133333333333333	150	8202	10010,3659	TANK,IRF1
R-HSA-5694530	Cargo concentration in the ER	0.121553253306549	-2.10740281340707	33	2	0.0133333333333333	150	8202	10484,7039	SEC23A,TGFA
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.123737064769118	-2.08959641011492	67	3	0.02	150	8202	26503,85365,29926	SLC17A5,ALG2,GMPPA
R-HSA-5654738	Signaling by FGFR2	0.124636617780524	-2.0823528331351	316	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-190236	Signaling by FGFR	0.12637956544942	-2.06846547608695	317	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-1222556	ROS production in response to bacteria	0.127668275450474	-2.05831997710926	34	2	0.0133333333333333	150	8202	1535,523	CYBA,ATP6V1A
R-HSA-2559583	Cellular Senescence	0.127755606883423	-2.05763616136302	187	6	0.04	150	8202	1912,23043,51434,4193,1026,3397	PHC2,TNIK,ANAPC7,MDM2,CDKN1A,ID1
R-HSA-75109	Triglyceride Biosynthesis	0.127808922782183	-2.05721892114895	68	3	0.02	150	8202	51495,84803,6576	HACD3,GPAT3,SLC25A1
R-HSA-909733	Interferon alpha/beta signaling	0.127808922782183	-2.05721892114895	68	3	0.02	150	8202	4940,6773,3659	OAS3,STAT2,IRF1
R-HSA-597592	Post-translational protein modification	0.131612022026899	-2.02789691147535	411	11	0.0733333333333333	150	8202	1912,2517,10484,10678,7039,85365,672,26503,79642,29926,4121	PHC2,FUCA1,SEC23A,B3GNT2,TGFA,ALG2,BRCA1,SLC17A5,ARSJ,GMPPA,MAN1A1
R-HSA-1227986	Signaling by ERBB2	0.131687113876634	-2.02732651954061	320	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.137330638420652	-1.98536384164385	8	1	0.00666666666666667	150	8202	301	ANXA1
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.137330638420652	-1.98536384164385	8	1	0.00666666666666667	150	8202	54894	RNF43
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.137330638420652	-1.98536384164385	8	1	0.00666666666666667	150	8202	6513	SLC2A1
R-HSA-428643	Organic anion transporters	0.137330638420652	-1.98536384164385	8	1	0.00666666666666667	150	8202	26503	SLC17A5
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.137330638420652	-1.98536384164385	8	1	0.00666666666666667	150	8202	37	ACADVL
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.137330638420652	-1.98536384164385	8	1	0.00666666666666667	150	8202	1535	CYBA
R-HSA-1483148	Synthesis of PG	0.137330638420652	-1.98536384164385	8	1	0.00666666666666667	150	8202	8760	CDS2
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.140107154739567	-1.96534775813824	36	2	0.0133333333333333	150	8202	1591,2232	CYP24A1,FDXR
R-HSA-5655302	Signaling by FGFR1 in disease	0.140107154739567	-1.96534775813824	36	2	0.0133333333333333	150	8202	2254,5290	FGF9,PIK3CA
R-HSA-2424491	DAP12 signaling	0.140792248918278	-1.96046988706984	325	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-157118	Signaling by NOTCH	0.142086418312902	-1.95131982682206	110	4	0.0266666666666667	150	8202	7088,182,92737,23220	TLE1,JAG1,DNER,DTX4
R-HSA-438064	Post NMDA receptor activation events	0.14642195427849	-1.9212627277793	37	2	0.0133333333333333	150	8202	817,2905	CAMK2D,GRIN2C
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.152794522391969	-1.87866125111238	38	2	0.0133333333333333	150	8202	317,2810	APAF1,SFN
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.153122730711896	-1.87651551763364	9	1	0.00666666666666667	150	8202	2232	FDXR
R-HSA-196108	Pregnenolone biosynthesis	0.153122730711896	-1.87651551763364	9	1	0.00666666666666667	150	8202	2232	FDXR
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.153122730711896	-1.87651551763364	9	1	0.00666666666666667	150	8202	160	AP2A1
R-HSA-73614	Pyrimidine salvage reactions	0.153122730711896	-1.87651551763364	9	1	0.00666666666666667	150	8202	1890	TYMP
R-HSA-2179392	EGFR Transactivation by Gastrin	0.153122730711896	-1.87651551763364	9	1	0.00666666666666667	150	8202	1956	EGFR
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.154628515820164	-1.86672971080663	198	6	0.04	150	8202	2254,5720,4193,1026,1956,5290	FGF9,PSME1,MDM2,CDKN1A,EGFR,PIK3CA
R-HSA-416482	G alpha (12/13) signalling events	0.157572013272864	-1.84787269808363	75	3	0.02	150	8202	7074,9475,5290	TIAM1,ROCK2,PIK3CA
R-HSA-202403	TCR signaling	0.159140089641411	-1.83797039774643	115	4	0.0266666666666667	150	8202	5588,5720,3635,5290	PRKCQ,PSME1,INPP5D,PIK3CA
R-HSA-166520	Signalling by NGF	0.163317229907042	-1.81206077381199	430	11	0.0733333333333333	150	8202	2254,817,4193,2905,160,5290,5720,1026,7414,7074,1956	FGF9,CAMK2D,MDM2,GRIN2C,AP2A1,PIK3CA,PSME1,CDKN1A,VCL,TIAM1,EGFR
R-HSA-419812	Calcitonin-like ligand receptors	0.168627623961599	-1.78006240364661	10	1	0.00666666666666667	150	8202	133	ADM
R-HSA-2562578	TRIF-mediated programmed cell death	0.168627623961599	-1.78006240364661	10	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-2161522	Abacavir transport and metabolism	0.168627623961599	-1.78006240364661	10	1	0.00666666666666667	150	8202	5243	ABCB1
R-HSA-2172127	DAP12 interactions	0.169980956014668	-1.7720688716501	340	9	0.06	150	8202	2254,817,4193,2905,5290,5720,1026,7414,1956	FGF9,CAMK2D,MDM2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.17221765843169	-1.75899614618508	41	2	0.0133333333333333	150	8202	817,2905	CAMK2D,GRIN2C
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.178780766783682	-1.72159499035253	42	2	0.0133333333333333	150	8202	7088,6662	TLE1,SOX9
R-HSA-879518	Transport of organic anions	0.183850506824619	-1.6936323145097	11	1	0.00666666666666667	150	8202	28232	SLCO3A1
R-HSA-3371378	Regulation by c-FLIP	0.183850506824619	-1.6936323145097	11	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-1980148	Signaling by NOTCH3	0.183850506824619	-1.6936323145097	11	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-5218900	CASP8 activity is inhibited	0.183850506824619	-1.6936323145097	11	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-5655291	Signaling by FGFR4 in disease	0.183850506824619	-1.6936323145097	11	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-69416	Dimerization of procaspase-8	0.183850506824619	-1.6936323145097	11	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.183850506824619	-1.6936323145097	11	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.183850506824619	-1.6936323145097	11	1	0.00666666666666667	150	8202	1535	CYBA
R-HSA-1980150	Signaling by NOTCH4	0.183850506824619	-1.6936323145097	11	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-1236975	Antigen processing-Cross presentation	0.184605168636051	-1.68953595819348	81	3	0.02	150	8202	5720,6892,1535	PSME1,TAPBP,CYBA
R-HSA-917937	Iron uptake and transport	0.185382010842681	-1.685336659454	43	2	0.0133333333333333	150	8202	30061,523	SLC40A1,ATP6V1A
R-HSA-74752	Signaling by Insulin receptor	0.192749639752264	-1.64636313553	304	8	0.0533333333333333	150	8202	2254,817,2905,523,5290,5720,7414,1956	FGF9,CAMK2D,GRIN2C,ATP6V1A,PIK3CA,PSME1,VCL,EGFR
R-HSA-392499	Metabolism of proteins	0.197474806722236	-1.62214426367761	943	21	0.14	150	8202	516,10484,10678,3489,7039,6235,6142,26503,136,672,79642,29926,4189,4000,4121,2517,1912,2934,1471,85365,37	ATP5G1,SEC23A,B3GNT2,IGFBP6,TGFA,RPS29,RPL18A,SLC17A5,ADORA2B,BRCA1,ARSJ,GMPPA,DNAJB9,LMNA,MAN1A1,FUCA1,PHC2,GSN,CST3,ALG2,ACADVL
R-HSA-1226099	Signaling by FGFR in disease	0.198684792306419	-1.61603566830498	45	2	0.0133333333333333	150	8202	2254,5290	FGF9,PIK3CA
R-HSA-2160916	Hyaluronan uptake and degradation	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	960	CD44
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	2810	SFN
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-190373	FGFR1c ligand binding and activation	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-210990	PECAM1 interactions	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	3635	INPP5D
R-HSA-190239	FGFR3 ligand binding and activation	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-2033514	FGFR3 mutant receptor activation	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-211979	Eicosanoids	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	66002	CYP4F12
R-HSA-190372	FGFR3c ligand binding and activation	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-432047	Passive transport by Aquaporins	0.198796474837316	-1.61547371712354	12	1	0.00666666666666667	150	8202	360	AQP3
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.205379559173577	-1.58289550360841	46	2	0.0133333333333333	150	8202	51495,6576	HACD3,SLC25A1
R-HSA-381119	Unfolded Protein Response (UPR)	0.207997682135939	-1.57022834292013	86	3	0.02	150	8202	37,4189,4000	ACADVL,DNAJB9,LMNA
R-HSA-425407	SLC-mediated transmembrane transport	0.208817994893715	-1.56629224424598	264	7	0.0466666666666667	150	8202	30061,26503,28232,6505,204962,6513,9123	SLC40A1,SLC17A5,SLCO3A1,SLC1A1,SLC44A5,SLC2A1,SLC16A3
R-HSA-449147	Signaling by Interleukins	0.209285670072213	-1.56405511784536	311	8	0.0533333333333333	150	8202	2254,817,2905,3635,5290,5720,7414,1956	FGF9,CAMK2D,GRIN2C,INPP5D,PIK3CA,PSME1,VCL,EGFR
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.212755784479148	-1.54761032280709	87	3	0.02	150	8202	677,5720,3304	ZFP36L1,PSME1,HSPA1B
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	51	ACOX1
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	51	ACOX1
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	6513	SLC2A1
R-HSA-75205	Dissolution of Fibrin Clot	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	6281	S100A10
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	23220	DTX4
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	4000	LMNA
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	160	AP2A1
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	8821	INPP4B
R-HSA-2995410	Nuclear Envelope Reassembly	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	4000	LMNA
R-HSA-4641265	Repression of WNT target genes	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	7088	TLE1
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	64428	NARFL
R-HSA-1483213	Synthesis of PE	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	1119	CHKA
R-HSA-190375	FGFR2c ligand binding and activation	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-177504	Retrograde neurotrophin signalling	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	160	AP2A1
R-HSA-1663150	The activation of arylsulfatases	0.213470532073381	-1.54425647891502	13	1	0.00666666666666667	150	8202	79642	ARSJ
R-HSA-211945	Phase 1 - Functionalization of compounds	0.222342020614062	-1.5035384492713	89	3	0.02	150	8202	1591,66002,2232	CYP24A1,CYP4F12,FDXR
R-HSA-3371568	Attenuation phase	0.227877592783558	-1.47894666795234	14	1	0.00666666666666667	150	8202	3304	HSPA1B
R-HSA-190322	FGFR4 ligand binding and activation	0.227877592783558	-1.47894666795234	14	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.227877592783558	-1.47894666795234	14	1	0.00666666666666667	150	8202	10371	SEMA3A
R-HSA-5675482	Regulation of necroptotic cell death	0.227877592783558	-1.47894666795234	14	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.238692695315259	-1.43257834805257	228	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.238692695315259	-1.43257834805257	228	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-180336	SHC1 events in EGFR signaling	0.238692695315259	-1.43257834805257	228	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-5673001	RAF/MAP kinase cascade	0.238692695315259	-1.43257834805257	228	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-179812	GRB2 events in EGFR signaling	0.238692695315259	-1.43257834805257	228	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-112412	SOS-mediated signalling	0.238692695315259	-1.43257834805257	228	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.238692695315259	-1.43257834805257	228	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-383280	Nuclear Receptor transcription pathway	0.23916152766137	-1.43061610737748	51	2	0.0133333333333333	150	8202	5468,7025	PPARG,NR2F1
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.241716701345739	-1.41998889417407	229	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.241716701345739	-1.41998889417407	229	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.241716701345739	-1.41998889417407	229	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.241716701345739	-1.41998889417407	229	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.242022483000815	-1.4187246521788	15	1	0.00666666666666667	150	8202	4000	LMNA
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.242022483000815	-1.4187246521788	15	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-211935	Fatty acids	0.242022483000815	-1.4187246521788	15	1	0.00666666666666667	150	8202	66002	CYP4F12
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.242022483000815	-1.4187246521788	15	1	0.00666666666666667	150	8202	23220	DTX4
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.242022483000815	-1.4187246521788	15	1	0.00666666666666667	150	8202	2810	SFN
R-HSA-159418	Recycling of bile acids and salts	0.242022483000815	-1.4187246521788	15	1	0.00666666666666667	150	8202	8714	ABCC3
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.242022483000815	-1.4187246521788	15	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.242022483000815	-1.4187246521788	15	1	0.00666666666666667	150	8202	9564	BCAR1
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.242022483000815	-1.4187246521788	15	1	0.00666666666666667	150	8202	160	AP2A1
R-HSA-112399	IRS-mediated signalling	0.243746375186297	-1.41162704024533	277	7	0.0466666666666667	150	8202	2254,817,5720,7414,2905,1956,5290	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR,PIK3CA
R-HSA-69541	Stabilization of p53	0.245959187620076	-1.40258966079679	52	2	0.0133333333333333	150	8202	5720,4193	PSME1,MDM2
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.245959187620076	-1.40258966079679	52	2	0.0133333333333333	150	8202	26503,29926	SLC17A5,GMPPA
R-HSA-170984	ARMS-mediated activation	0.250857675236341	-1.3828695316041	232	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-187706	Signalling to p38 via RIT and RIN	0.250857675236341	-1.3828695316041	232	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-74751	Insulin receptor signalling cascade	0.252065918178709	-1.37806464560257	280	7	0.0466666666666667	150	8202	2254,817,5720,7414,2905,1956,5290	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR,PIK3CA
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.252764272432003	-1.37529795410215	53	2	0.0133333333333333	150	8202	5720,60489	PSME1,APOBEC3G
R-HSA-170968	Frs2-mediated activation	0.253926790550841	-1.37070927968654	233	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-2428924	IGF1R signaling cascade	0.254858565247479	-1.36704653378507	281	7	0.0466666666666667	150	8202	2254,817,5720,7414,2905,1956,5290	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR,PIK3CA
R-HSA-2428928	IRS-related events triggered by IGF1R	0.254858565247479	-1.36704653378507	281	7	0.0466666666666667	150	8202	2254,817,5720,7414,2905,1956,5290	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR,PIK3CA
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.254858565247479	-1.36704653378507	281	7	0.0466666666666667	150	8202	2254,817,5720,7414,2905,1956,5290	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR,PIK3CA
R-HSA-399956	CRMPs in Sema3A signaling	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	10371	SEMA3A
R-HSA-5218859	Regulated Necrosis	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	136	ADORA2B
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	516	ATP5G1
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	10371	SEMA3A
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	160	AP2A1
R-HSA-1834941	STING mediated induction of host immune responses	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	23220	DTX4
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-190242	FGFR1 ligand binding and activation	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-1369062	ABC transporters in lipid homeostasis	0.255909942088121	-1.36292968511302	16	1	0.00666666666666667	150	8202	5825	ABCD3
R-HSA-5684996	MAPK1/MAPK3 signaling	0.257006535834374	-1.35865376314813	234	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-2262752	Cellular responses to stress	0.257305306494595	-1.35749193614265	379	9	0.06	150	8202	1912,847,23043,817,4193,3397,51434,1026,3304	PHC2,CAT,TNIK,CAMK2D,MDM2,ID1,ANAPC7,CDKN1A,HSPA1B
R-HSA-169893	Prolonged ERK activation events	0.260096651179878	-1.34670198173584	235	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.261452061689967	-1.34150433277967	97	3	0.02	150	8202	8737,10010,1660	RIPK1,TANK,DHX9
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.261452061689967	-1.34150433277967	97	3	0.02	150	8202	8737,10010,1660	RIPK1,TANK,DHX9
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.261452061689967	-1.34150433277967	97	3	0.02	150	8202	8737,10010,1660	RIPK1,TANK,DHX9
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.26169468526585	-1.34057677815111	142	4	0.0266666666666667	150	8202	817,4193,2905,160	CAMK2D,MDM2,GRIN2C,AP2A1
R-HSA-2586552	Signaling by Leptin	0.263196876294864	-1.33485294778201	236	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.266386698253581	-1.32280627304307	55	2	0.0133333333333333	150	8202	5720,3304	PSME1,HSPA1B
R-HSA-2187338	Visual phototransduction	0.266408547103237	-1.32272425710971	98	3	0.02	150	8202	5588,9249,157506	PRKCQ,DHRS3,RDH10
R-HSA-2033519	Activated point mutants of FGFR2	0.269544624316803	-1.31102132045972	17	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.269544624316803	-1.31102132045972	17	1	0.00666666666666667	150	8202	51434	ANAPC7
R-HSA-1839126	FGFR2 mutant receptor activation	0.269544624316803	-1.31102132045972	17	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-176412	Phosphorylation of the APC/C	0.269544624316803	-1.31102132045972	17	1	0.00666666666666667	150	8202	51434	ANAPC7
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.269544624316803	-1.31102132045972	17	1	0.00666666666666667	150	8202	677	ZFP36L1
R-HSA-140534	Ligand-dependent caspase activation	0.269544624316803	-1.31102132045972	17	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-5627117	RHO GTPases Activate ROCKs	0.269544624316803	-1.31102132045972	17	1	0.00666666666666667	150	8202	9475	ROCK2
R-HSA-1482801	Acyl chain remodelling of PS	0.269544624316803	-1.31102132045972	17	1	0.00666666666666667	150	8202	10162	LPCAT3
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.269544624316803	-1.31102132045972	17	1	0.00666666666666667	150	8202	37	ACADVL
R-HSA-167044	Signalling to RAS	0.272555603142002	-1.29991263746632	239	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.273199249586782	-1.29755389804337	56	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-382551	Transmembrane transport of small molecules	0.274198395270682	-1.29390336427556	586	13	0.0866666666666667	150	8202	30061,523,5825,6513,5243,9123,6446,8714,360,26503,28232,6505,204962	SLC40A1,ATP6V1A,ABCD3,SLC2A1,ABCB1,SLC16A3,SGK1,ABCC3,AQP3,SLC17A5,SLCO3A1,SLC1A1,SLC44A5
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.27884052042632	-1.27711527196803	241	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-1280215	Cytokine Signaling in Immune system	0.281366444993049	-1.26809738450693	539	12	0.08	150	8202	2254,817,2905,3635,5290,5720,4940,960,7414,1956,6773,3659	FGF9,CAMK2D,GRIN2C,INPP5D,PIK3CA,PSME1,OAS3,CD44,VCL,EGFR,STAT2,IRF1
R-HSA-211859	Biological oxidations	0.28173521484311	-1.26678760359495	194	5	0.0333333333333333	150	8202	1591,2941,6819,66002,2232	CYP24A1,GSTA4,SULT1C2,CYP4F12,FDXR
R-HSA-913531	Interferon Signaling	0.28173521484311	-1.26678760359495	194	5	0.0333333333333333	150	8202	817,4940,960,6773,3659	CAMK2D,OAS3,CD44,STAT2,IRF1
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.282931100349359	-1.26255187264355	18	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.282931100349359	-1.26255187264355	18	1	0.00666666666666667	150	8202	10010	TANK
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.282931100349359	-1.26255187264355	18	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.282931100349359	-1.26255187264355	18	1	0.00666666666666667	150	8202	51434	ANAPC7
R-HSA-912631	Regulation of signaling by CBL	0.282931100349359	-1.26255187264355	18	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-156584	Cytosolic sulfonation of small molecules	0.282931100349359	-1.26255187264355	18	1	0.00666666666666667	150	8202	6819	SULT1C2
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.282931100349359	-1.26255187264355	18	1	0.00666666666666667	150	8202	51434	ANAPC7
R-HSA-210993	Tie2 Signaling	0.282931100349359	-1.26255187264355	18	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-2132295	MHC class II antigen presentation	0.286339041992021	-1.25057870875639	102	3	0.02	150	8202	10484,79659,160	SEC23A,DYNC2H1,AP2A1
R-HSA-187687	Signalling to ERKs	0.294697764189291	-1.22180497600194	246	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-69618	Mitotic Spindle Checkpoint	0.296073858765781	-1.21714633292636	19	1	0.00666666666666667	150	8202	51434	ANAPC7
R-HSA-168249	Innate Immune System	0.299136501978499	-1.20685528141263	752	16	0.106666666666667	150	8202	2254,1660,8737,5588,5720,1026,837,1956,817,4193,2905,10010,5290,23220,7414,3659	FGF9,DHX9,RIPK1,PRKCQ,PSME1,CDKN1A,CASP4,EGFR,CAMK2D,MDM2,GRIN2C,TANK,PIK3CA,DTX4,VCL,IRF1
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.300406401209849	-1.20261905036497	60	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-2871796	FCERI mediated MAPK activation	0.301093167113647	-1.20033553683183	248	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-421270	Cell-cell junction organization	0.307187084333737	-1.18029832177691	61	2	0.0133333333333333	150	8202	81607,25945	PVRL4,PVRL3
R-HSA-190241	FGFR2 ligand binding and activation	0.308977307528312	-1.17448744320083	20	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-2028269	Signaling by Hippo	0.308977307528312	-1.17448744320083	20	1	0.00666666666666667	150	8202	154796	AMOT
R-HSA-3000170	Syndecan interactions	0.308977307528312	-1.17448744320083	20	1	0.00666666666666667	150	8202	3691	ITGB4
R-HSA-1643685	Disease	0.314506210418651	-1.15675145607747	657	14	0.0933333333333333	150	8202	2254,182,4193,160,6235,2232,5290,6142,5720,54894,1026,60489,1956,3304	FGF9,JAG1,MDM2,AP2A1,RPS29,FDXR,PIK3CA,RPL18A,PSME1,RNF43,CDKN1A,APOBEC3G,EGFR,HSPA1B
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	160	AP2A1
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	79586	CHPF
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-4641263	Regulation of FZD by ubiquitination	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	54894	RNF43
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	3489	IGFBP6
R-HSA-390918	Peroxisomal lipid metabolism	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	51	ACOX1
R-HSA-445144	Signal transduction by L1	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	1956	EGFR
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	51434	ANAPC7
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.32164577537632	-1.13430441543703	21	1	0.00666666666666667	150	8202	50484	RRM2B
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.327448089714404	-1.11642574115887	64	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-1236974	ER-Phagosome pathway	0.327448089714404	-1.11642574115887	64	2	0.0133333333333333	150	8202	5720,6892	PSME1,TAPBP
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.334083513261545	-1.09636427755493	22	1	0.00666666666666667	150	8202	157506	RDH10
R-HSA-373753	Nephrin interactions	0.334083513261545	-1.09636427755493	22	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.334083513261545	-1.09636427755493	22	1	0.00666666666666667	150	8202	2517	FUCA1
R-HSA-69202	Cyclin E associated events during G1/S transition	0.334168943968685	-1.09610859362386	65	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-166054	Activated TLR4 signalling	0.336555335901729	-1.08899269794384	112	3	0.02	150	8202	8737,10010,1660	RIPK1,TANK,DHX9
R-HSA-1280218	Adaptive Immune System	0.336906542697623	-1.0879497084625	668	14	0.0933333333333333	150	8202	10484,2254,6892,4193,1535,3635,160,5290,5588,51434,5720,1026,79659,1956	SEC23A,FGF9,TAPBP,MDM2,CYBA,INPP5D,AP2A1,PIK3CA,PRKCQ,ANAPC7,PSME1,CDKN1A,DYNC2H1,EGFR
R-HSA-112315	Transmission across Chemical Synapses	0.3392803751784	-1.08092844800882	210	5	0.0333333333333333	150	8202	817,4193,2905,160,6505	CAMK2D,MDM2,GRIN2C,AP2A1,SLC1A1
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.340870659127765	-1.07625217239614	66	2	0.0133333333333333	150	8202	10484,7039	SEC23A,TGFA
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.340870659127765	-1.07625217239614	66	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-73980	RNA Polymerase III Transcription Termination	0.346294695783049	-1.06046514451737	23	1	0.00666666666666667	150	8202	4781	NFIB
R-HSA-429947	Deadenylation of mRNA	0.346294695783049	-1.06046514451737	23	1	0.00666666666666667	150	8202	85456	TNKS1BP1
R-HSA-1482839	Acyl chain remodelling of PE	0.346294695783049	-1.06046514451737	23	1	0.00666666666666667	150	8202	10162	LPCAT3
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.346294695783049	-1.06046514451737	23	1	0.00666666666666667	150	8202	51434	ANAPC7
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.346294695783049	-1.06046514451737	23	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-211976	Endogenous sterols	0.346294695783049	-1.06046514451737	23	1	0.00666666666666667	150	8202	2232	FDXR
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.346294695783049	-1.06046514451737	23	1	0.00666666666666667	150	8202	4048	LTA4H
R-HSA-201451	Signaling by BMP	0.346294695783049	-1.06046514451737	23	1	0.00666666666666667	150	8202	650	BMP2
R-HSA-216083	Integrin cell surface interactions	0.347551692804902	-1.05684186876731	67	2	0.0133333333333333	150	8202	3675,960	ITGA3,CD44
R-HSA-373755	Semaphorin interactions	0.347551692804902	-1.05684186876731	67	2	0.0133333333333333	150	8202	10371,9475	SEMA3A,ROCK2
R-HSA-199977	ER to Golgi Anterograde Transport	0.354210564621782	-1.03786372736511	68	2	0.0133333333333333	150	8202	10484,7039	SEC23A,TGFA
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.358283422476785	-1.02643092290099	24	1	0.00666666666666667	150	8202	9475	ROCK2
R-HSA-70268	Pyruvate metabolism	0.358283422476785	-1.02643092290099	24	1	0.00666666666666667	150	8202	9123	SLC16A3
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.358283422476785	-1.02643092290099	24	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-933542	TRAF6 mediated NF-kB activation	0.358283422476785	-1.02643092290099	24	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.358283422476785	-1.02643092290099	24	1	0.00666666666666667	150	8202	6505	SLC1A1
R-HSA-375165	NCAM signaling for neurite out-growth	0.359615609032858	-1.02271957067249	266	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.360845854527987	-1.01930440760526	69	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.360845854527987	-1.01930440760526	69	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-68949	Orc1 removal from chromatin	0.367456201093572	-1.00115114812959	70	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-69052	Switching of origins to a post-replicative state	0.367456201093572	-1.00115114812959	70	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.367456201093572	-1.00115114812959	70	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-69473	G2/M DNA damage checkpoint	0.367456201093572	-1.00115114812959	70	2	0.0133333333333333	150	8202	672,2810	BRCA1,SFN
R-HSA-168256	Immune System	0.368347415960322	-0.998728721052832	1371	27	0.18	150	8202	10484,2254,523,3635,1660,8737,5588,5720,1026,837,1956,6773,6892,817,4193,1535,2905,160,10010,5290,23220,51434,4940,79659,960,7414,3659	SEC23A,FGF9,ATP6V1A,INPP5D,DHX9,RIPK1,PRKCQ,PSME1,CDKN1A,CASP4,EGFR,STAT2,TAPBP,CAMK2D,MDM2,CYBA,GRIN2C,AP2A1,TANK,PIK3CA,DTX4,ANAPC7,OAS3,DYNC2H1,CD44,VCL,IRF1
R-HSA-114452	Activation of BH3-only proteins	0.370053719209397	-0.994107096830064	25	1	0.00666666666666667	150	8202	2810	SFN
R-HSA-1482788	Acyl chain remodelling of PC	0.370053719209397	-0.994107096830064	25	1	0.00666666666666667	150	8202	10162	LPCAT3
R-HSA-425410	Metal ion SLC transporters	0.370053719209397	-0.994107096830064	25	1	0.00666666666666667	150	8202	30061	SLC40A1
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.370053719209397	-0.994107096830064	25	1	0.00666666666666667	150	8202	51495	HACD3
R-HSA-2559580	Oxidative Stress Induced Senescence	0.371666457783951	-0.98975844577246	119	3	0.02	150	8202	1912,23043,4193	PHC2,TNIK,MDM2
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.371836915764028	-0.989299919317498	424	9	0.06	150	8202	2254,817,2905,5290,5720,5588,7414,1956,301	FGF9,CAMK2D,GRIN2C,PIK3CA,PSME1,PRKCQ,VCL,EGFR,ANXA1
R-HSA-69300	Removal of licensing factors from origins	0.380596901716005	-0.966014464678695	72	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.380596901716005	-0.966014464678695	72	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.38160953944858	-0.963357341165485	26	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.38160953944858	-0.963357341165485	26	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-912694	Regulation of IFNA signaling	0.38160953944858	-0.963357341165485	26	1	0.00666666666666667	150	8202	6773	STAT2
R-HSA-2029485	Role of phospholipids in phagocytosis	0.38160953944858	-0.963357341165485	26	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.38160953944858	-0.963357341165485	26	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-77387	Insulin receptor recycling	0.38160953944858	-0.963357341165485	26	1	0.00666666666666667	150	8202	523	ATP6V1A
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.38160953944858	-0.963357341165485	26	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.381646281701342	-0.963261063477789	121	3	0.02	150	8202	8737,10010,1660	RIPK1,TANK,DHX9
R-HSA-5683057	MAPK family signaling cascades	0.382645154989913	-0.960647207534021	273	6	0.04	150	8202	2254,817,5720,7414,2905,1956	FGF9,CAMK2D,PSME1,VCL,GRIN2C,EGFR
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.387124811433362	-0.949008127783852	73	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-195721	Signaling by Wnt	0.38731763825173	-0.948510151924107	326	7	0.0466666666666667	150	8202	7088,54894,5720,51384,79971,160,6662	TLE1,RNF43,PSME1,WNT16,WLS,AP2A1,SOX9
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.392954765600284	-0.934060773991149	27	1	0.00666666666666667	150	8202	9564	BCAR1
R-HSA-180024	DARPP-32 events	0.392954765600284	-0.934060773991149	27	1	0.00666666666666667	150	8202	5142	PDE4B
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.392954765600284	-0.934060773991149	27	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-114508	Effects of PIP2 hydrolysis	0.392954765600284	-0.934060773991149	27	1	0.00666666666666667	150	8202	5588	PRKCQ
R-HSA-400685	Sema4D in semaphorin signaling	0.392954765600284	-0.934060773991149	27	1	0.00666666666666667	150	8202	9475	ROCK2
R-HSA-437239	Recycling pathway of L1	0.392954765600284	-0.934060773991149	27	1	0.00666666666666667	150	8202	160	AP2A1
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.392954765600284	-0.934060773991149	27	1	0.00666666666666667	150	8202	3635	INPP5D
R-HSA-1368082	RORA activates gene expression	0.392954765600284	-0.934060773991149	27	1	0.00666666666666667	150	8202	85441	HELZ2
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.393622885989165	-0.932361970196737	74	2	0.0133333333333333	150	8202	1912,672	PHC2,BRCA1
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.393622885989165	-0.932361970196737	74	2	0.0133333333333333	150	8202	1912,672	PHC2,BRCA1
R-HSA-194840	Rho GTPase cycle	0.39655115958718	-0.924950218268002	124	3	0.02	150	8202	58480,7074,23526	RHOU,TIAM1,HMHA1
R-HSA-69304	Regulation of DNA replication	0.400090033192732	-0.916065674219699	75	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-1221632	Meiotic synapsis	0.400090033192732	-0.916065674219699	75	2	0.0133333333333333	150	8202	672,4000	BRCA1,LMNA
R-HSA-2022854	Keratan sulfate biosynthesis	0.404093210276798	-0.906109709125482	28	1	0.00666666666666667	150	8202	10678	B3GNT2
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.404093210276798	-0.906109709125482	28	1	0.00666666666666667	150	8202	160	AP2A1
R-HSA-1483166	Synthesis of PA	0.404093210276798	-0.906109709125482	28	1	0.00666666666666667	150	8202	84803	GPAT3
R-HSA-162909	Host Interactions of HIV factors	0.411362296672578	-0.888280952359328	127	3	0.02	150	8202	5720,160,60489	PSME1,AP2A1,APOBEC3G
R-HSA-2871837	FCERI mediated NF-kB activation	0.412927421964222	-0.884483435206891	77	2	0.0133333333333333	150	8202	5588,5720	PRKCQ,PSME1
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.412927421964222	-0.884483435206891	77	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-445355	Smooth Muscle Contraction	0.415028617481566	-0.879407803342012	29	1	0.00666666666666667	150	8202	7414	VCL
R-HSA-917977	Transferrin endocytosis and recycling	0.415028617481566	-0.879407803342012	29	1	0.00666666666666667	150	8202	523	ATP6V1A
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.415028617481566	-0.879407803342012	29	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.415028617481566	-0.879407803342012	29	1	0.00666666666666667	150	8202	847	CAT
R-HSA-418346	Platelet homeostasis	0.419295720194	-0.869178831883509	78	2	0.0133333333333333	150	8202	10846,5139	PDE10A,PDE3A
R-HSA-2990846	SUMOylation	0.425629201625536	-0.854186730466501	79	2	0.0133333333333333	150	8202	1912,672	PHC2,BRCA1
R-HSA-109704	PI3K Cascade	0.425629201625536	-0.854186730466501	79	2	0.0133333333333333	150	8202	2254,5290	FGF9,PIK3CA
R-HSA-5683826	Surfactant metabolism	0.425764663897279	-0.853868517525649	30	1	0.00666666666666667	150	8202	136	ADORA2B
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.436304960078367	-0.829413830413029	31	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-2129379	Molecules associated with elastic fibres	0.436304960078367	-0.829413830413029	31	1	0.00666666666666667	150	8202	650	BMP2
R-HSA-70263	Gluconeogenesis	0.436304960078367	-0.829413830413029	31	1	0.00666666666666667	150	8202	6576	SLC25A1
R-HSA-168638	NOD1/2 Signaling Pathway	0.436304960078367	-0.829413830413029	31	1	0.00666666666666667	150	8202	837	CASP4
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.436304960078367	-0.829413830413029	31	1	0.00666666666666667	150	8202	3304	HSPA1B
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.436304960078367	-0.829413830413029	31	1	0.00666666666666667	150	8202	4325	MMP16
R-HSA-5357905	Regulation of TNFR1 signaling	0.436304960078367	-0.829413830413029	31	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.438188319256824	-0.825106508367693	81	2	0.0133333333333333	150	8202	7088,5720	TLE1,PSME1
R-HSA-1980145	Signaling by NOTCH2	0.446653051617486	-0.805973156623248	32	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.446653051617486	-0.805973156623248	32	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-389356	CD28 co-stimulation	0.446653051617486	-0.805973156623248	32	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-453276	Regulation of mitotic cell cycle	0.450598403647862	-0.79717879371583	83	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.450598403647862	-0.79717879371583	83	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-168255	Influenza Life Cycle	0.455071072840019	-0.787301668185769	136	3	0.02	150	8202	6142,6235,3304	RPL18A,RPS29,HSPA1B
R-HSA-192823	Viral mRNA Translation	0.456745743985985	-0.783628401805781	84	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-156902	Peptide chain elongation	0.456745743985985	-0.783628401805781	84	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-351202	Metabolism of polyamines	0.456745743985985	-0.783628401805781	84	2	0.0133333333333333	150	8202	5720,6303	PSME1,SAT1
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.456812420312554	-0.783482431183891	33	1	0.00666666666666667	150	8202	5087	PBX1
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.456812420312554	-0.783482431183891	33	1	0.00666666666666667	150	8202	10678	B3GNT2
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.456812420312554	-0.783482431183891	33	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-4085001	Sialic acid metabolism	0.456812420312554	-0.783482431183891	33	1	0.00666666666666667	150	8202	26503	SLC17A5
R-HSA-72764	Eukaryotic Translation Termination	0.462853725658831	-0.770344202114187	85	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-390522	Striated Muscle Contraction	0.466786485313189	-0.761883330760078	34	1	0.00666666666666667	150	8202	7431	VIM
R-HSA-4791275	Signaling by WNT in cancer	0.466786485313189	-0.761883330760078	34	1	0.00666666666666667	150	8202	54894	RNF43
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.466786485313189	-0.761883330760078	34	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-3928663	EPHA-mediated growth cone collapse	0.466786485313189	-0.761883330760078	34	1	0.00666666666666667	150	8202	9475	ROCK2
R-HSA-5693537	Resolution of D-Loop Structures	0.466786485313189	-0.761883330760078	34	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.466786485313189	-0.761883330760078	34	1	0.00666666666666667	150	8202	5588	PRKCQ
R-HSA-1474290	Collagen formation	0.46892172669855	-0.757319418497159	86	2	0.0133333333333333	150	8202	1308,3691	COL17A1,ITGB4
R-HSA-3371556	Cellular response to heat stress	0.46892172669855	-0.757319418497159	86	2	0.0133333333333333	150	8202	817,3304	CAMK2D,HSPA1B
R-HSA-168898	Toll-Like Receptors Cascades	0.474074328605271	-0.746391158177158	140	3	0.02	150	8202	8737,10010,1660	RIPK1,TANK,DHX9
R-HSA-373080	Class B/2 (Secretin family receptors)	0.474949160637788	-0.744547510911875	87	2	0.0133333333333333	150	8202	51384,133	WNT16,ADM
R-HSA-2514856	The phototransduction cascade	0.476578604214024	-0.741122607868159	35	1	0.00666666666666667	150	8202	5588	PRKCQ
R-HSA-194068	Bile acid and bile salt metabolism	0.476578604214024	-0.741122607868159	35	1	0.00666666666666667	150	8202	8714	ABCC3
R-HSA-977225	Amyloid formation	0.480935475463296	-0.732022164520796	88	2	0.0133333333333333	150	8202	2934,1471	GSN,CST3
R-HSA-156842	Eukaryotic Translation Elongation	0.480935475463296	-0.732022164520796	88	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.486192074193873	-0.721151518767595	36	1	0.00666666666666667	150	8202	79642	ARSJ
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.486192074193873	-0.721151518767595	36	1	0.00666666666666667	150	8202	1956	EGFR
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.486880152589202	-0.719737279431451	89	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.488129739332672	-0.717174049175046	143	3	0.02	150	8202	516,4719,9123	ATP5G1,NDUFS1,SLC16A3
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.495630133089644	-0.701925329845357	37	1	0.00666666666666667	150	8202	9564	BCAR1
R-HSA-156590	Glutathione conjugation	0.495630133089644	-0.701925329845357	37	1	0.00666666666666667	150	8202	2941	GSTA4
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.495630133089644	-0.701925329845357	37	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.495630133089644	-0.701925329845357	37	1	0.00666666666666667	150	8202	1956	EGFR
R-HSA-4086400	PCP/CE pathway	0.498642680236624	-0.695865511402484	91	2	0.0133333333333333	150	8202	5720,160	PSME1,AP2A1
R-HSA-5674135	MAP2K and MAPK activation	0.50489596040386	-0.683402889933865	38	1	0.00666666666666667	150	8202	7414	VCL
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.50489596040386	-0.683402889933865	38	1	0.00666666666666667	150	8202	1643	DDB2
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.50489596040386	-0.683402889933865	38	1	0.00666666666666667	150	8202	28232	SLCO3A1
R-HSA-69236	G1 Phase	0.50489596040386	-0.683402889933865	38	1	0.00666666666666667	150	8202	1026	CDKN1A
R-HSA-1442490	Collagen degradation	0.50489596040386	-0.683402889933865	38	1	0.00666666666666667	150	8202	1308	COL17A1
R-HSA-69231	Cyclin D associated events in G1	0.50489596040386	-0.683402889933865	38	1	0.00666666666666667	150	8202	1026	CDKN1A
R-HSA-168254	Influenza Infection	0.506586826449057	-0.68005954560372	147	3	0.02	150	8202	6142,6235,3304	RPL18A,RPS29,HSPA1B
R-HSA-6783310	Fanconi Anemia Pathway	0.513992678427839	-0.665546257932239	39	1	0.00666666666666667	150	8202	2189	FANCG
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.513992678427839	-0.665546257932239	39	1	0.00666666666666667	150	8202	2152	F3
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.513992678427839	-0.665546257932239	39	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-72689	Formation of a pool of free 40S subunits	0.515963033319422	-0.661720156920736	94	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.522923353199829	-0.648320377856217	40	1	0.00666666666666667	150	8202	4781	NFIB
R-HSA-1660662	Glycosphingolipid metabolism	0.522923353199829	-0.648320377856217	40	1	0.00666666666666667	150	8202	79642	ARSJ
R-HSA-5696400	Dual Incision in GG-NER	0.522923353199829	-0.648320377856217	40	1	0.00666666666666667	150	8202	1643	DDB2
R-HSA-74158	RNA Polymerase III Transcription	0.522923353199829	-0.648320377856217	40	1	0.00666666666666667	150	8202	4781	NFIB
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.527290028808201	-0.640004542527407	96	2	0.0133333333333333	150	8202	26503,6505	SLC17A5,SLC1A1
R-HSA-75893	TNF signaling	0.531690995569158	-0.631692793787038	41	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-5620924	Intraflagellar transport	0.531690995569158	-0.631692793787038	41	1	0.00666666666666667	150	8202	79659	DYNC2H1
R-HSA-70153	Glucose transport	0.531690995569158	-0.631692793787038	41	1	0.00666666666666667	150	8202	6513	SLC2A1
R-HSA-69239	Synthesis of DNA	0.538438244053551	-0.619082470385416	98	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-156580	Phase II conjugation	0.538438244053551	-0.619082470385416	98	2	0.0133333333333333	150	8202	2941,6819	GSTA4,SULT1C2
R-HSA-373752	Netrin-1 signaling	0.540298562129701	-0.615633399379965	42	1	0.00666666666666667	150	8202	5588	PRKCQ
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.540298562129701	-0.615633399379965	42	1	0.00666666666666667	150	8202	85441	HELZ2
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.540298562129701	-0.615633399379965	42	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-1566948	Elastic fibre formation	0.540298562129701	-0.615633399379965	42	1	0.00666666666666667	150	8202	650	BMP2
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.540298562129701	-0.615633399379965	42	1	0.00666666666666667	150	8202	85441	HELZ2
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.54279305206743	-0.611027151273888	267	5	0.0333333333333333	150	8202	10484,51434,5720,6892,1535	SEC23A,ANAPC7,PSME1,TAPBP,CYBA
R-HSA-5610787	Hedgehog 'off' state	0.543944671492477	-0.608907744113984	99	2	0.0133333333333333	150	8202	5720,79659	PSME1,DYNC2H1
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.548748956219383	-0.600114216700473	43	1	0.00666666666666667	150	8202	360	AQP3
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.557045028836189	-0.585109200605692	44	1	0.00666666666666667	150	8202	1643	DDB2
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.560190740282885	-0.579477945598549	102	2	0.0133333333333333	150	8202	516,4719	ATP5G1,NDUFS1
R-HSA-5668914	Diseases of metabolism	0.565189579674019	-0.570594064870349	45	1	0.00666666666666667	150	8202	2232	FDXR
R-HSA-193648	NRAGE signals death through JNK	0.565189579674019	-0.570594064870349	45	1	0.00666666666666667	150	8202	7074	TIAM1
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.565189579674019	-0.570594064870349	45	1	0.00666666666666667	150	8202	9123	SLC16A3
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.570792139978878	-0.560730163658432	104	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.573185357904778	-0.55654612783314	46	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-418597	G alpha (z) signalling events	0.573185357904778	-0.55654612783314	46	1	0.00666666666666667	150	8202	5588	PRKCQ
R-HSA-69481	G2/M Checkpoints	0.57602366481904	-0.551606534374923	105	2	0.0133333333333333	150	8202	672,2810	BRCA1,SFN
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.57602366481904	-0.551606534374923	105	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.57602366481904	-0.551606534374923	105	2	0.0133333333333333	150	8202	51434,1026	ANAPC7,CDKN1A
R-HSA-189200	Hexose transport	0.581035063192354	-0.542944174222533	47	1	0.00666666666666667	150	8202	6513	SLC2A1
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.581035063192354	-0.542944174222533	47	1	0.00666666666666667	150	8202	837	CASP4
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.581035063192354	-0.542944174222533	47	1	0.00666666666666667	150	8202	7088	TLE1
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.581208949534712	-0.542644949031004	106	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.581208949534712	-0.542644949031004	106	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-69306	DNA Replication	0.581208949534712	-0.542644949031004	106	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.586347924875811	-0.533841937135114	107	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.588741346520376	-0.52976833181409	48	1	0.00666666666666667	150	8202	6235	RPS29
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.588741346520376	-0.52976833181409	48	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-73887	Death Receptor Signalling	0.588741346520376	-0.52976833181409	48	1	0.00666666666666667	150	8202	8737	RIPK1
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.588741346520376	-0.52976833181409	48	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.596306811081071	-0.516999960679384	49	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.596306811081071	-0.516999960679384	49	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.596306811081071	-0.516999960679384	49	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-69206	G1/S Transition	0.596486759003835	-0.516698235504733	109	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.603734013135222	-0.504621553645072	50	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.603734013135222	-0.504621553645072	50	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-169911	Regulation of Apoptosis	0.603734013135222	-0.504621553645072	50	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-2980766	Nuclear Envelope Breakdown	0.603734013135222	-0.504621553645072	50	1	0.00666666666666667	150	8202	4000	LMNA
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.603734013135222	-0.504621553645072	50	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-429914	Deadenylation-dependent mRNA decay	0.603734013135222	-0.504621553645072	50	1	0.00666666666666667	150	8202	85456	TNKS1BP1
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.603734013135222	-0.504621553645072	50	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-112310	Neurotransmitter Release Cycle	0.603734013135222	-0.504621553645072	50	1	0.00666666666666667	150	8202	6505	SLC1A1
R-HSA-201681	TCF dependent signaling in response to WNT	0.607517969821944	-0.498373524251094	229	4	0.0266666666666667	150	8202	7088,54894,5720,6662	TLE1,RNF43,PSME1,SOX9
R-HSA-76002	Platelet activation, signaling and aggregation	0.610973534107884	-0.492701636447737	230	4	0.0266666666666667	150	8202	5588,9564,7414,5290	PRKCQ,BCAR1,VCL,PIK3CA
R-HSA-180534	Vpu mediated degradation of CD4	0.611025462832347	-0.492616646648851	51	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.611025462832347	-0.492616646648851	51	1	0.00666666666666667	150	8202	79586	CHPF
R-HSA-445717	Aquaporin-mediated transport	0.611025462832347	-0.492616646648851	51	1	0.00666666666666667	150	8202	360	AQP3
R-HSA-397795	G-protein beta:gamma signalling	0.611025462832347	-0.492616646648851	51	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-1592230	Mitochondrial biogenesis	0.611025462832347	-0.492616646648851	51	1	0.00666666666666667	150	8202	85441	HELZ2
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.611025462832347	-0.492616646648851	51	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.611025462832347	-0.492616646648851	51	1	0.00666666666666667	150	8202	2254	FGF9
R-HSA-72737	Cap-dependent Translation Initiation	0.611346952377267	-0.492090637474672	112	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-72613	Eukaryotic Translation Initiation	0.611346952377267	-0.492090637474672	112	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-68882	Mitotic Anaphase	0.61344150388419	-0.488670367569128	172	3	0.02	150	8202	51434,5720,4000	ANAPC7,PSME1,LMNA
R-HSA-112316	Neuronal System	0.613802494788478	-0.488082072307404	289	5	0.0333333333333333	150	8202	817,4193,2905,160,6505	CAMK2D,MDM2,GRIN2C,AP2A1,SLC1A1
R-HSA-5663205	Infectious disease	0.614419359446848	-0.487077588128735	347	6	0.04	150	8202	6142,5720,160,60489,6235,3304	RPL18A,PSME1,AP2A1,APOBEC3G,RPS29,HSPA1B
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.617382766517786	-0.482266080297197	173	3	0.02	150	8202	51434,5720,4000	ANAPC7,PSME1,LMNA
R-HSA-1268020	Mitochondrial protein import	0.618183625087833	-0.480969737684382	52	1	0.00666666666666667	150	8202	516	ATP5G1
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.618183625087833	-0.480969737684382	52	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.618183625087833	-0.480969737684382	52	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-69610	p53-Independent DNA Damage Response	0.618183625087833	-0.480969737684382	52	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-1500620	Meiosis	0.625789892499387	-0.468740599205071	115	2	0.0133333333333333	150	8202	672,4000	BRCA1,LMNA
R-HSA-114604	GPVI-mediated activation cascade	0.632109725339926	-0.458692283860615	54	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.632109725339926	-0.458692283860615	54	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-4641257	Degradation of AXIN	0.632109725339926	-0.458692283860615	54	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.632109725339926	-0.458692283860615	54	1	0.00666666666666667	150	8202	3691	ITGB4
R-HSA-72702	Ribosomal scanning and start codon recognition	0.638882373997185	-0.448034919800749	55	1	0.00666666666666667	150	8202	6235	RPS29
R-HSA-72649	Translation initiation complex formation	0.638882373997185	-0.448034919800749	55	1	0.00666666666666667	150	8202	6235	RPS29
R-HSA-2142753	Arachidonic acid metabolism	0.638882373997185	-0.448034919800749	55	1	0.00666666666666667	150	8202	4048	LTA4H
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.638882373997185	-0.448034919800749	55	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.638882373997185	-0.448034919800749	55	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-4641258	Degradation of DVL	0.64553115807717	-0.43768180018235	56	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.64553115807717	-0.43768180018235	56	1	0.00666666666666667	150	8202	6235	RPS29
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.652058328001686	-0.427621260931517	57	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.652058328001686	-0.427621260931517	57	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.652058328001686	-0.427621260931517	57	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.652058328001686	-0.427621260931517	57	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.652058328001686	-0.427621260931517	57	1	0.00666666666666667	150	8202	182	JAG1
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.658466093606208	-0.417842249471919	58	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.658466093606208	-0.417842249471919	58	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.664756624778457	-0.40833428308925	59	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.664756624778457	-0.40833428308925	59	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.664756624778457	-0.40833428308925	59	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.664756624778457	-0.40833428308925	59	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-69242	S Phase	0.6709467271226	-0.399065538422177	125	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.67699446843715	-0.390092176801692	61	1	0.00666666666666667	150	8202	7074	TIAM1
R-HSA-162582	Signal Transduction	0.678858570234536	-0.387342464378967	2357	41	0.273333333333333	150	8202	7433,523,6662,5142,8737,54894,5720,1026,136,92737,9249,5139,650,4193,182,2905,10846,220,5290,79659,51384,7414,7074,154796,9475,2254,79971,23526,157506,5588,9564,133,1956,301,58480,817,1535,160,23220,7088,2810	VIPR1,ATP6V1A,SOX9,PDE4B,RIPK1,RNF43,PSME1,CDKN1A,ADORA2B,DNER,DHRS3,PDE3A,BMP2,MDM2,JAG1,GRIN2C,PDE10A,ALDH1A3,PIK3CA,DYNC2H1,WNT16,VCL,TIAM1,AMOT,ROCK2,FGF9,WLS,HMHA1,RDH10,PRKCQ,BCAR1,ADM,EGFR,ANXA1,RHOU,CAMK2D,CYBA,AP2A1,DTX4,TLE1,SFN
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.679434628952644	-0.386494254650772	127	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-416476	G alpha (q) signalling events	0.680217998262662	-0.385341946508209	190	3	0.02	150	8202	5588,5290,301	PRKCQ,PIK3CA,ANXA1
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.682945927681654	-0.381339591386281	62	1	0.00666666666666667	150	8202	2810	SFN
R-HSA-400253	Circadian Clock	0.688788447447621	-0.372821098007495	63	1	0.00666666666666667	150	8202	85441	HELZ2
R-HSA-4608870	Asymmetric localization of PCP proteins	0.688788447447621	-0.372821098007495	63	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-212436	Generic Transcription Pathway	0.690085777349979	-0.370939374117332	553	9	0.06	150	8202	85441,143686,860,5468,50484,80818,27244,2810,7025	HELZ2,SESN3,RUNX2,PPARG,RRM2B,ZNF436,SESN1,SFN,NR2F1
R-HSA-5358346	Hedgehog ligand biogenesis	0.69452400868224	-0.364528547648412	64	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-913709	O-linked glycosylation of mucins	0.69452400868224	-0.364528547648412	64	1	0.00666666666666667	150	8202	10678	B3GNT2
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.69452400868224	-0.364528547648412	64	1	0.00666666666666667	150	8202	1308	COL17A1
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.70015455656811	-0.356454173213082	65	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-1169091	Activation of NF-kappaB in B cells	0.70568200113667	-0.348590566279114	66	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5658442	Regulation of RAS by GAPs	0.711108217943097	-0.34093065549639	67	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-68867	Assembly of the pre-replicative complex	0.711108217943097	-0.34093065549639	67	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-453279	Mitotic G1-G1/S phases	0.71162405284847	-0.340205522681782	135	2	0.0133333333333333	150	8202	5720,1026	PSME1,CDKN1A
R-HSA-5358351	Signaling by Hedgehog	0.71162405284847	-0.340205522681782	135	2	0.0133333333333333	150	8202	5720,79659	PSME1,DYNC2H1
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.716435048581072	-0.333467686791455	68	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.716435048581072	-0.333467686791455	68	1	0.00666666666666667	150	8202	3304	HSPA1B
R-HSA-388841	Costimulation by the CD28 family	0.716435048581072	-0.333467686791455	68	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.719239934779821	-0.329560270698003	137	2	0.0133333333333333	150	8202	50808,3659	AK3,IRF1
R-HSA-3858494	Beta-catenin independent WNT signaling	0.744581716579966	-0.294932672532118	144	2	0.0133333333333333	150	8202	5720,160	PSME1,AP2A1
R-HSA-194315	Signaling by Rho GTPases	0.744753333238307	-0.294702211751487	399	6	0.04	150	8202	58480,1535,7074,9475,23526,2810	RHOU,CYBA,TIAM1,ROCK2,HMHA1,SFN
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.746407935806124	-0.292482997396569	74	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-5693606	DNA Double Strand Break Response	0.751087907467899	-0.286232580182922	75	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-72766	Translation	0.751455952499833	-0.285742684281577	146	2	0.0133333333333333	150	8202	6142,6235	RPL18A,RPS29
R-HSA-428157	Sphingolipid metabolism	0.755682076770009	-0.280134524624565	76	1	0.00666666666666667	150	8202	79642	ARSJ
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.760192006425553	-0.274184237576258	77	1	0.00666666666666667	150	8202	1026	CDKN1A
R-HSA-70326	Glucose metabolism	0.760192006425553	-0.274184237576258	77	1	0.00666666666666667	150	8202	6576	SLC25A1
R-HSA-422356	Regulation of insulin secretion	0.773231563901199	-0.257176710053343	80	1	0.00666666666666667	150	8202	6513	SLC2A1
R-HSA-162906	HIV Infection	0.774614372913346	-0.255389956802078	221	3	0.02	150	8202	5720,160,60489	PSME1,AP2A1,APOBEC3G
R-HSA-611105	Respiratory electron transport	0.77741960446846	-0.25177504288808	81	1	0.00666666666666667	150	8202	4719	NDUFS1
R-HSA-114608	Platelet degranulation	0.77741960446846	-0.25177504288808	81	1	0.00666666666666667	150	8202	7414	VCL
R-HSA-68874	M/G1 Transition	0.781530804984628	-0.246500712130827	82	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.781530804984628	-0.246500712130827	82	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.781530804984628	-0.246500712130827	82	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-193704	p75 NTR receptor-mediated signalling	0.781530804984628	-0.246500712130827	82	1	0.00666666666666667	150	8202	7074	TIAM1
R-HSA-69002	DNA Replication Pre-Initiation	0.781530804984628	-0.246500712130827	82	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.781530804984628	-0.246500712130827	82	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.785566565968647	-0.241350081441405	83	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.785566565968647	-0.241350081441405	83	1	0.00666666666666667	150	8202	1643	DDB2
R-HSA-912446	Meiotic recombination	0.789528262618625	-0.236319647803523	84	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-5632684	Hedgehog 'on' state	0.789528262618625	-0.236319647803523	84	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-111885	Opioid Signalling	0.789528262618625	-0.236319647803523	84	1	0.00666666666666667	150	8202	5142	PDE4B
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.79341724519514	-0.231406035323733	85	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.79341724519514	-0.231406035323733	85	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.79723483953489	-0.226605989221487	86	1	0.00666666666666667	150	8202	5290	PIK3CA
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.79723483953489	-0.226605989221487	86	1	0.00666666666666667	150	8202	7414	VCL
R-HSA-2467813	Separation of Sister Chromatids	0.798125186829053	-0.225489818110408	161	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.800982347433602	-0.221916370316918	87	1	0.00666666666666667	150	8202	7088	TLE1
R-HSA-5687128	MAPK6/MAPK4 signaling	0.804661047108473	-0.217334149726594	88	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.808272193642726	-0.212856403869914	89	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-196854	Metabolism of vitamins and cofactors	0.811817019339078	-0.208480309856133	90	1	0.00666666666666667	150	8202	6513	SLC2A1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.811817019339078	-0.208480309856133	90	1	0.00666666666666667	150	8202	6513	SLC2A1
R-HSA-5625740	RHO GTPases activate PKNs	0.811817019339078	-0.208480309856133	90	1	0.00666666666666667	150	8202	2810	SFN
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.818712526348897	-0.200022262424982	92	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.818712526348897	-0.200022262424982	92	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.818712526348897	-0.200022262424982	92	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.818712526348897	-0.200022262424982	92	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.831759482906672	-0.184211962998352	96	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5693607	Processing of DNA double-strand break ends	0.834872741911337	-0.180475970642691	97	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-2672351	Stimuli-sensing channels	0.840928605374369	-0.173248515152159	99	1	0.00666666666666667	150	8202	6446	SGK1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.840928605374369	-0.173248515152159	99	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-5173105	O-linked glycosylation	0.852386323903936	-0.159715423109829	103	1	0.00666666666666667	150	8202	10678	B3GNT2
R-HSA-199991	Membrane Trafficking	0.852622045549073	-0.159438918136761	256	3	0.02	150	8202	10484,7039,2810	SEC23A,TGFA,SFN
R-HSA-163685	Integration of energy metabolism	0.863023862773078	-0.147312937327249	107	1	0.00666666666666667	150	8202	6513	SLC2A1
R-HSA-5696398	Nucleotide Excision Repair	0.868053462313854	-0.141501973691048	109	1	0.00666666666666667	150	8202	1643	DDB2
R-HSA-72163	mRNA Splicing - Major Pathway	0.877568828495649	-0.13059988968606	113	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-372790	Signaling by GPCR	0.877676997812174	-0.13047663707376	1230	18	0.12	150	8202	7433,2254,5142,5588,5720,136,133,5139,1956,301,817,2905,10846,5290,51384,7074,7414,9475	VIPR1,FGF9,PDE4B,PRKCQ,PSME1,ADORA2B,ADM,PDE3A,EGFR,ANXA1,CAMK2D,GRIN2C,PDE10A,PIK3CA,WNT16,TIAM1,VCL,ROCK2
R-HSA-983712	Ion channel transport	0.881750688792058	-0.125845928701486	198	2	0.0133333333333333	150	8202	6446,523	SGK1,ATP6V1A
R-HSA-72172	mRNA Splicing	0.89260910628984	-0.113606524856215	120	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-195258	RHO GTPase Effectors	0.898416653913974	-0.10712133842565	285	3	0.02	150	8202	1535,9475,2810	CYBA,ROCK2,SFN
R-HSA-5621481	C-type lectin receptors (CLRs)	0.898478976925986	-0.107051971	123	1	0.00666666666666667	150	8202	5720	PSME1
R-HSA-71291	Metabolism of amino acids and derivatives	0.9040755717465	-0.100842325019288	212	2	0.0133333333333333	150	8202	5720,6303	PSME1,SAT1
R-HSA-1640170	Cell Cycle	0.906635199048848	-0.0980151158939205	572	7	0.0466666666666667	150	8202	51434,5720,4193,672,1026,2810,4000	ANAPC7,PSME1,MDM2,BRCA1,CDKN1A,SFN,LMNA
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.909279469159121	-0.0951027852370321	129	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-5653656	Vesicle-mediated transport	0.909792040239358	-0.0945392327970592	294	3	0.02	150	8202	10484,7039,2810	SEC23A,TGFA,SFN
R-HSA-68886	M Phase	0.912158993917425	-0.0919409686666887	296	3	0.02	150	8202	51434,5720,4000	ANAPC7,PSME1,LMNA
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.918803208720365	-0.0846833158785975	223	2	0.0133333333333333	150	8202	51434,5720	ANAPC7,PSME1
R-HSA-5693538	Homology Directed Repair	0.918937775149101	-0.0845368682233979	135	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-68875	Mitotic Prophase	0.920445068291245	-0.0828979560361861	136	1	0.00666666666666667	150	8202	4000	LMNA
R-HSA-73894	DNA Repair	0.923174415905672	-0.0799370960194987	306	3	0.02	150	8202	1643,672,2189	DDB2,BRCA1,FANCG
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.932817143948844	-0.0695460845358864	145	1	0.00666666666666667	150	8202	4781	NFIB
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.942198805423737	-0.0595389805754837	153	1	0.00666666666666667	150	8202	1660	DHX9
R-HSA-5693532	DNA Double-Strand Break Repair	0.951205420535972	-0.0500252349927313	162	1	0.00666666666666667	150	8202	672	BRCA1
R-HSA-388396	GPCR downstream signaling	0.960681760721114	-0.0401120791519838	928	11	0.0733333333333333	150	8202	7433,10846,5142,5290,5588,136,7074,9475,133,5139,301	VIPR1,PDE10A,PDE4B,PIK3CA,PRKCQ,ADORA2B,TIAM1,ROCK2,ADM,PDE3A,ANXA1
R-HSA-74160	Gene Expression	0.964836743403401	-0.0357963697756429	1330	17	0.113333333333333	150	8202	860,5468,6235,1660,677,5720,6142,85456,27244,4781,7025,3304,85441,143686,50484,80818,2810	RUNX2,PPARG,RPS29,DHX9,ZFP36L1,PSME1,RPL18A,TNKS1BP1,SESN1,NFIB,NR2F1,HSPA1B,HELZ2,SESN3,RRM2B,ZNF436,SFN
R-HSA-5617833	Assembly of the primary cilium	0.965247071379633	-0.0353711778961288	180	1	0.00666666666666667	150	8202	79659	DYNC2H1
R-HSA-500792	GPCR ligand binding	0.965752626326548	-0.034847557971105	444	4	0.0266666666666667	150	8202	51384,136,133,301	WNT16,ADORA2B,ADM,ANXA1
R-HSA-375276	Peptide ligand-binding receptors	0.972814181027116	-0.0275621903403882	193	1	0.00666666666666667	150	8202	301	ANXA1
R-HSA-69278	Cell Cycle, Mitotic	0.978042254633073	-0.0222024047343442	477	4	0.0266666666666667	150	8202	51434,5720,1026,4000	ANAPC7,PSME1,CDKN1A,LMNA
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.98200364441898	-0.0181602594136007	318	2	0.0133333333333333	150	8202	136,301	ADORA2B,ANXA1
R-HSA-1852241	Organelle biogenesis and maintenance	0.98286790878349	-0.0172805434659205	321	2	0.0133333333333333	150	8202	85441,79659	HELZ2,DYNC2H1
R-HSA-418594	G alpha (i) signalling events	0.987968181391119	-0.0121047868225818	236	1	0.00666666666666667	150	8202	301	ANXA1
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-209776	Amine-derived hormones	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-5635838	Activation of SMO	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-73780	RNA Polymerase III Chain Elongation	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.9999999999752	-2.48003864514317e-11	18	0	0	150	8202
R-HSA-416700	Other semaphorin interactions	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-3000480	Scavenging by Class A Receptors	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-110320	Translesion Synthesis by POLH	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-190861	Gap junction assembly	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-1181150	Signaling by NODAL	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-418360	Platelet calcium homeostasis	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.999999999978555	-2.14453808235012e-11	19	0	0	150	8202
R-HSA-168325	Viral Messenger RNA Synthesis	0.999999999980151	-1.98490135170235e-11	41	0	0	150	8202
R-HSA-167021	PLC-gamma1 signalling	0.999999999980504	-1.94955929121322e-11	36	0	0	150	8202
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.999999999980504	-1.94955929121322e-11	36	0	0	150	8202
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.999999999980504	-1.94955929121322e-11	36	0	0	150	8202
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.999999999980504	-1.94955929121322e-11	36	0	0	150	8202
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.999999999980504	-1.94955929121322e-11	36	0	0	150	8202
R-HSA-166663	Initial triggering of complement	0.999999999981541	-1.84587089796928e-11	20	0	0	150	8202
R-HSA-210745	Regulation of gene expression in beta cells	0.999999999981541	-1.84587089796928e-11	20	0	0	150	8202
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.999999999981541	-1.84587089796928e-11	20	0	0	150	8202
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.999999999981541	-1.84587089796928e-11	20	0	0	150	8202
R-HSA-418217	G beta:gamma signalling through PLC beta	0.999999999981541	-1.84587089796928e-11	20	0	0	150	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-389542	NADPH regeneration	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-3248023	Regulation by TREX1	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-169131	Inhibition of PKR	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1483076	Synthesis of CL	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-140180	COX reactions	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1300645	Acrosome Reaction	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5619084	ABC transporter disorders	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999981781	-1.82185724839634e-11	1	0	0	150	8202
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.999999999982962	-1.70375739158424e-11	72	0	0	150	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-75157	FasL/ CD95L signaling	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-5652084	Fructose metabolism	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-2161541	Abacavir metabolism	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-3000471	Scavenging by Class B Receptors	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-74713	IRS activation	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-167827	The proton buffering model	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-444209	Free fatty acid receptors	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-1614517	Sulfide oxidation to sulfate	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-197264	Nicotinamide salvaging	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-114516	Disinhibition of SNARE formation	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-390651	Dopamine receptors	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-71032	Propionyl-CoA catabolism	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-187024	NGF-independant TRKA activation	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-157881	Cyclin B2 mediated events	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-111463	SMAC binds to IAPs	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-112303	Electric Transmission Across Gap Junctions	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-561048	Organic anion transport	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-69478	G2/M DNA replication checkpoint	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-391906	Leukotriene receptors	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-68911	G2 Phase	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-426048	Arachidonate production from DAG	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-1169092	Activation of RAS in B cells	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-112307	Transmission across Electrical Synapses	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-167826	The fatty acid cycling model	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-111469	SMAC-mediated apoptotic response	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.99999999998452	-1.54799371088687e-11	5	0	0	150	8202
R-HSA-113510	E2F mediated regulation of DNA replication	0.999999999985895	-1.41048506785061e-11	33	0	0	150	8202
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.999999999985895	-1.41048506785061e-11	33	0	0	150	8202
R-HSA-69190	DNA strand elongation	0.999999999985895	-1.41048506785061e-11	33	0	0	150	8202
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.999999999985895	-1.41048506785061e-11	33	0	0	150	8202
R-HSA-163359	Glucagon signaling in metabolic regulation	0.999999999985895	-1.41048506785061e-11	33	0	0	150	8202
R-HSA-72187	mRNA 3'-end processing	0.999999999985895	-1.41048506785061e-11	33	0	0	150	8202
R-HSA-1251985	Nuclear signaling by ERBB4	0.999999999986061	-1.39393148470252e-11	40	0	0	150	8202
R-HSA-5675221	Negative regulation of MAPK pathway	0.999999999986061	-1.39393148470252e-11	40	0	0	150	8202
R-HSA-168253	Host Interactions with Influenza Factors	0.999999999986061	-1.39393148470252e-11	40	0	0	150	8202
R-HSA-109703	PKB-mediated events	0.999999999986061	-1.39393148470252e-11	40	0	0	150	8202
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.999999999986061	-1.39393148470252e-11	40	0	0	150	8202
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-162594	Early Phase of HIV Life Cycle	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-428540	Activation of Rac	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-2024101	CS/DS degradation	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-69166	Removal of the Flap Intermediate	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-418885	DCC mediated attractive signaling	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-5682910	LGI-ADAM interactions	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-69091	Polymerase switching	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-877312	Regulation of IFNG signaling	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-69109	Leading Strand Synthesis	0.999999999986356	-1.36437197496324e-11	14	0	0	150	8202
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-110312	Translesion synthesis by REV1	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-193639	p75NTR signals via NF-kB	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-156711	Polo-like kinase mediated events	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-1433559	Regulation of KIT signaling	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-392517	Rap1 signalling	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-163615	PKA activation	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-5625900	RHO GTPases activate CIT	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-69183	Processive synthesis on the lagging strand	0.999999999986481	-1.35186047228181e-11	16	0	0	150	8202
R-HSA-5423646	Aflatoxin activation and detoxification	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-203765	eNOS activation and regulation	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-5205647	Mitophagy	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-166208	mTORC1-mediated signalling	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-202131	Metabolism of nitric oxide	0.999999999987045	-1.2955158777678e-11	22	0	0	150	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-265473	Trafficking of dietary sterols	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-70350	Fructose catabolism	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-1483152	Hydrolysis of LPE	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-77108	Utilization of Ketone Bodies	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-191650	Regulation of gap junction activity	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-163282	Mitochondrial transcription initiation	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-193681	Ceramide signalling	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-977347	Serine biosynthesis	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-198745	Signalling to STAT3	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-844455	The NLRP1 inflammasome	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-177539	Autointegration results in viral DNA circles	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5357572	Lysosomal glycogen catabolism	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-110331	Cleavage of the damaged purine	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-3249367	STAT6-mediated induction of chemokines	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-1296067	Potassium transport channels	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-977442	GABA A (rho) receptor activation	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-217271	FMO oxidises nucleophiles	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5602571	TRAF3 deficiency - HSE	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-73927	Depurination	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-844615	The AIM2 inflammasome	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-1307965	betaKlotho-mediated ligand binding	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.99999999998715	-1.28502166632193e-11	3	0	0	150	8202
R-HSA-1461973	Defensins	0.999999999988195	-1.18045872081131e-11	51	0	0	150	8202
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.999999999988195	-1.18045872081131e-11	51	0	0	150	8202
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.999999999988376	-1.1624261157024e-11	27	0	0	150	8202
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999988376	-1.1624261157024e-11	27	0	0	150	8202
R-HSA-192105	Synthesis of bile acids and bile salts	0.999999999988376	-1.1624261157024e-11	27	0	0	150	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-916853	Degradation of GABA	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-168268	Virus Assembly and Release	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-1483101	Synthesis of PS	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-192905	vRNP Assembly	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-75102	C6 deamination of adenosine	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-844623	The IPAF inflammasome	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-380612	Metabolism of serotonin	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-156582	Acetylation	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-888568	GABA synthesis	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-165160	PDE3B signalling	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-198765	Signalling to ERK5	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-70688	Proline catabolism	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-187042	TRKA activation by NGF	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-75094	Formation of the Editosome	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-111995	phospho-PLA2 pathway	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-1483226	Synthesis of PI	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999988922	-1.10784732082481e-11	2	0	0	150	8202
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-392518	Signal amplification	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-202433	Generation of second messenger molecules	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-186712	Regulation of beta-cell development	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-73863	RNA Polymerase I Transcription Termination	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-376176	Signaling by Robo receptor	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.99999999998912	-1.08797987453205e-11	32	0	0	150	8202
R-HSA-68877	Mitotic Prometaphase	0.999999999989342	-1.06583283059536e-11	108	0	0	150	8202
R-HSA-2022923	Dermatan sulfate biosynthesis	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-5625970	RHO GTPases activate KTN1	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-196780	Biotin transport and metabolism	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-71288	Creatine metabolism	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-376172	DSCAM interactions	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-199983	Golgi to ER Retrograde Transport	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-199997	COPI Mediated Transport	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-196757	Metabolism of folate and pterines	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-71064	Lysine catabolism	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-1059683	Interleukin-6 signaling	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-1266695	Interleukin-7 signaling	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-211999	CYP2E1 reactions	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-1236977	Endosomal/Vacuolar pathway	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-193048	Androgen biosynthesis	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-71240	Tryptophan catabolism	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-189451	Heme biosynthesis	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-196807	Nicotinate metabolism	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999989529	-1.04705519490021e-11	11	0	0	150	8202
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.999999999989857	-1.01427427373127e-11	24	0	0	150	8202
R-HSA-379716	Cytosolic tRNA aminoacylation	0.999999999989857	-1.01427427373127e-11	24	0	0	150	8202
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999989857	-1.01427427373127e-11	24	0	0	150	8202
R-HSA-977606	Regulation of Complement cascade	0.999999999989857	-1.01427427373127e-11	24	0	0	150	8202
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.999999999989857	-1.01427427373127e-11	24	0	0	150	8202
R-HSA-5260271	Diseases of Immune System	0.999999999989857	-1.01427427373127e-11	24	0	0	150	8202
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.999999999989857	-1.01427427373127e-11	24	0	0	150	8202
R-HSA-113418	Formation of the Early Elongation Complex	0.999999999990223	-9.77718407001472e-12	34	0	0	150	8202
R-HSA-1489509	DAG and IP3 signaling	0.999999999990223	-9.77718407001472e-12	34	0	0	150	8202
R-HSA-177243	Interactions of Rev with host cellular proteins	0.999999999990223	-9.77718407001472e-12	34	0	0	150	8202
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.999999999990223	-9.77718407001472e-12	34	0	0	150	8202
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.999999999990223	-9.77718407001472e-12	34	0	0	150	8202
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.999999999990223	-9.77718407001472e-12	34	0	0	150	8202
R-HSA-167287	HIV elongation arrest and recovery	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-1296065	Inwardly rectifying K+ channels	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-352230	Amino acid transport across the plasma membrane	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-167290	Pausing and recovery of HIV elongation	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-73772	RNA Polymerase I Promoter Escape	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-70171	Glycolysis	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-2022928	HS-GAG biosynthesis	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-180746	Nuclear import of Rev protein	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.999999999990499	-9.50063072108831e-12	31	0	0	150	8202
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-3781865	Diseases of glycosylation	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-1474165	Reproduction	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-264876	Insulin processing	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-983189	Kinesins	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-975298	Ligand-gated ion channel transport	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-1187000	Fertilization	0.999999999990674	-9.32553660354568e-12	26	0	0	150	8202
R-HSA-164944	Nef and signal transduction	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-5619115	Disorders of transmembrane transporters	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-1483115	Hydrolysis of LPC	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-400451	Free fatty acids regulate insulin secretion	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-73928	Depyrimidination	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-804914	Transport of fatty acids	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-196783	Coenzyme A biosynthesis	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-444821	Relaxin receptors	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-72731	Recycling of eIF2:GDP	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-5632681	Ligand-receptor interactions	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-1614558	Degradation of cysteine and homocysteine	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-2046105	Linoleic acid (LA) metabolism	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-192456	Digestion of dietary lipid	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999991192	-8.80810585146468e-12	8	0	0	150	8202
R-HSA-5334118	DNA methylation	0.999999999991223	-8.77696909058477e-12	62	0	0	150	8202
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.999999999991457	-8.54341127618808e-12	70	0	0	150	8202
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.999999999991457	-8.54341127618808e-12	70	0	0	150	8202
R-HSA-212300	PRC2 methylates histones and DNA	0.999999999991457	-8.54341127618808e-12	70	0	0	150	8202
R-HSA-1169408	ISG15 antiviral mechanism	0.999999999991457	-8.54341127618808e-12	70	0	0	150	8202
R-HSA-421837	Clathrin derived vesicle budding	0.999999999991457	-8.54341127618808e-12	70	0	0	150	8202
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.999999999991457	-8.54341127618808e-12	70	0	0	150	8202
R-HSA-774815	Nucleosome assembly	0.999999999991457	-8.54341127618808e-12	70	0	0	150	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-156587	Amino Acid conjugation	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-391908	Prostanoid ligand receptors	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-162592	Integration of provirus	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-1300642	Sperm Motility And Taxes	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-425986	Sodium/Proton exchangers	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-425381	Bicarbonate transporters	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-70635	Urea cycle	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-390696	Adrenoceptors	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-727802	Transport of nucleotide sugars	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-193697	p75NTR regulates axonogenesis	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-447041	CHL1 interactions	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-2428933	SHC-related events triggered by IGF1R	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-3215018	Processing and activation of SUMO	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-1462054	Alpha-defensins	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999992193	-7.80652486340519e-12	9	0	0	150	8202
R-HSA-3322077	Glycogen synthesis	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-209952	Peptide hormone biosynthesis	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-391903	Eicosanoid ligand-binding receptors	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-901042	Calnexin/calreticulin cycle	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-549132	Organic cation/anion/zwitterion transport	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-194223	HDL-mediated lipid transport	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-205043	NRIF signals cell death from the nucleus	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-975577	N-Glycan antennae elongation	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-5358508	Mismatch Repair	0.99999999999249	-7.51038833572756e-12	15	0	0	150	8202
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.999999999993522	-6.47815193470215e-12	77	0	0	150	8202
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.999999999993747	-6.25322591742341e-12	90	0	0	150	8202
R-HSA-5368287	Mitochondrial translation	0.999999999993747	-6.25322591742341e-12	90	0	0	150	8202
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.999999999993786	-6.21394911384467e-12	37	0	0	150	8202
R-HSA-419037	NCAM1 interactions	0.999999999993786	-6.21394911384467e-12	37	0	0	150	8202
R-HSA-176187	Activation of ATR in response to replication stress	0.999999999993786	-6.21394911384467e-12	37	0	0	150	8202
R-HSA-166658	Complement cascade	0.999999999993902	-6.09778275873249e-12	38	0	0	150	8202
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.999999999993902	-6.09778275873249e-12	38	0	0	150	8202
R-HSA-73728	RNA Polymerase I Promoter Opening	0.999999999993909	-6.09104981023343e-12	60	0	0	150	8202
R-HSA-450294	MAP kinase activation in TLR cascade	0.999999999993909	-6.09104981023343e-12	60	0	0	150	8202
R-HSA-73923	Lipid digestion, mobilization, and transport	0.999999999993909	-6.09104981023343e-12	60	0	0	150	8202
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.999999999994292	-5.70764841583515e-12	44	0	0	150	8202
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.999999999994292	-5.70764841583515e-12	44	0	0	150	8202
R-HSA-112382	Formation of RNA Pol II elongation complex	0.999999999994292	-5.70764841583515e-12	44	0	0	150	8202
R-HSA-446652	Interleukin-1 signaling	0.999999999994292	-5.70764841583515e-12	44	0	0	150	8202
R-HSA-69275	G2/M Transition	0.999999999994314	-5.68641789725385e-12	115	0	0	150	8202
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.999999999994314	-5.68641789725385e-12	115	0	0	150	8202
R-HSA-1296071	Potassium Channels	0.999999999994332	-5.66768508501784e-12	99	0	0	150	8202
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.999999999994518	-5.48239227511983e-12	39	0	0	150	8202
R-HSA-977444	GABA B receptor activation	0.999999999994518	-5.48239227511983e-12	39	0	0	150	8202
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.999999999994518	-5.48239227511983e-12	39	0	0	150	8202
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.999999999994518	-5.48239227511983e-12	39	0	0	150	8202
R-HSA-991365	Activation of GABAB receptors	0.999999999994518	-5.48239227511983e-12	39	0	0	150	8202
R-HSA-165159	mTOR signalling	0.999999999994518	-5.48239227511983e-12	39	0	0	150	8202
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.999999999994518	-5.48239227511983e-12	39	0	0	150	8202
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-168799	Neurotoxicity of clostridium toxins	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-209968	Thyroxine biosynthesis	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-381183	ATF6-alpha activates chaperone genes	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-419771	Opsins	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-3229121	Glycogen storage diseases	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-2474795	Diseases associated with visual transduction	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-74749	Signal attenuation	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-418886	Netrin mediated repulsion signals	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-549127	Organic cation transport	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-110056	MAPK3 (ERK1) activation	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-399997	Acetylcholine regulates insulin secretion	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-2453864	Retinoid cycle disease events	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-5621480	Dectin-2 family	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-190377	FGFR2b ligand binding and activation	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-190873	Gap junction degradation	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999995368	-4.63184603209481e-12	10	0	0	150	8202
R-HSA-390466	Chaperonin-mediated protein folding	0.999999999995492	-4.508058159966e-12	49	0	0	150	8202
R-HSA-936837	Ion transport by P-type ATPases	0.999999999995492	-4.508058159966e-12	49	0	0	150	8202
R-HSA-171306	Packaging Of Telomere Ends	0.999999999995492	-4.508058159966e-12	49	0	0	150	8202
R-HSA-2980736	Peptide hormone metabolism	0.999999999995528	-4.47223048797533e-12	86	0	0	150	8202
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.999999999995958	-4.04168252338581e-12	63	0	0	150	8202
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.999999999995958	-4.04168252338581e-12	63	0	0	150	8202
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.999999999995958	-4.04168252338581e-12	63	0	0	150	8202
R-HSA-2299718	Condensation of Prophase Chromosomes	0.999999999996005	-3.9948102886665e-12	71	0	0	150	8202
R-HSA-4086398	Ca2+ pathway	0.999999999996101	-3.89849782568418e-12	61	0	0	150	8202
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.999999999996101	-3.89849782568418e-12	61	0	0	150	8202
R-HSA-380287	Centrosome maturation	0.999999999996115	-3.88534958895232e-12	73	0	0	150	8202
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.999999999996115	-3.88534958895232e-12	73	0	0	150	8202
R-HSA-73856	RNA Polymerase II Transcription Termination	0.999999999996253	-3.74737251061335e-12	42	0	0	150	8202
R-HSA-379724	tRNA Aminoacylation	0.999999999996253	-3.74737251061335e-12	42	0	0	150	8202
R-HSA-975634	Retinoid metabolism and transport	0.999999999996253	-3.74737251061335e-12	42	0	0	150	8202
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.999999999996253	-3.74737251061335e-12	42	0	0	150	8202
R-HSA-375280	Amine ligand-binding receptors	0.999999999996253	-3.74737251061335e-12	42	0	0	150	8202
R-HSA-1461957	Beta defensins	0.999999999996253	-3.74737251061335e-12	42	0	0	150	8202
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.999999999996253	-3.74737251061335e-12	42	0	0	150	8202
R-HSA-162599	Late Phase of HIV Life Cycle	0.999999999996678	-3.32170256839349e-12	127	0	0	150	8202
R-HSA-5663220	RHO GTPases Activate Formins	0.999999999996756	-3.24382938548428e-12	114	0	0	150	8202
R-HSA-73864	RNA Polymerase I Transcription	0.999999999996861	-3.13910373294983e-12	109	0	0	150	8202
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.999999999996994	-3.00560637334945e-12	65	0	0	150	8202
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.999999999996994	-3.00560637334945e-12	65	0	0	150	8202
R-HSA-6782135	Dual incision in TC-NER	0.999999999997509	-2.49146013651641e-12	64	0	0	150	8202
R-HSA-3214841	PKMTs methylate histone lysines	0.999999999997509	-2.49146013651641e-12	64	0	0	150	8202
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.999999999997509	-2.49146013651641e-12	64	0	0	150	8202
R-HSA-211000	Gene Silencing by RNA	0.999999999997529	-2.47082076193952e-12	130	0	0	150	8202
R-HSA-1502540	Signaling by Activin	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-209560	NF-kB is activated and signals survival	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-211227	Activation of DNA fragmentation factor	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-2029481	FCGR activation	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-350054	Notch-HLH transcription pathway	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-174403	Glutathione synthesis and recycling	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-977441	GABA A receptor activation	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-5210891	Uptake and function of anthrax toxins	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-171007	p38MAPK events	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-74217	Purine salvage	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-209543	p75NTR recruits signalling complexes	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-140342	Apoptosis induced DNA fragmentation	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-209822	Glycoprotein hormones	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-5626467	RHO GTPases activate IQGAPs	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-75892	Platelet Adhesion to exposed collagen	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-175474	Assembly Of The HIV Virion	0.999999999997579	-2.4207584991489e-12	13	0	0	150	8202
R-HSA-5336415	Uptake and function of diphtheria toxin	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-68952	DNA replication initiation	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-70921	Histidine catabolism	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-388479	Vasopressin-like receptors	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-500753	Pyrimidine biosynthesis	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-171052	LDL-mediated lipid transport	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-190370	FGFR1b ligand binding and activation	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-176417	Phosphorylation of Emi1	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-1237112	Methionine salvage pathway	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-1566977	Fibronectin matrix formation	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-171319	Telomere Extension By Telomerase	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-174362	Transport and synthesis of PAPS	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-77111	Synthesis of Ketone Bodies	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-205025	NADE modulates death signalling	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-111957	Cam-PDE 1 activation	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-187015	Activation of TRKA receptors	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-3065679	SUMO is proteolytically processed	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-174430	Telomere C-strand synthesis initiation	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-73942	DNA Damage Reversal	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-428808	Na+-dependent glucose transporters	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-444257	RSK activation	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-166662	Lectin pathway of complement activation	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-3000484	Scavenging by Class F Receptors	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-189483	Heme degradation	0.999999999998353	-1.64695496233362e-12	6	0	0	150	8202
R-HSA-5578749	Transcriptional regulation by small RNAs	0.999999999998363	-1.63715001770415e-12	101	0	0	150	8202
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.999999999998447	-1.55332872320108e-12	45	0	0	150	8202
R-HSA-432720	Lysosome Vesicle Biogenesis	0.999999999998558	-1.44147303232439e-12	35	0	0	150	8202
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.999999999998558	-1.44147303232439e-12	35	0	0	150	8202
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.999999999998558	-1.44147303232439e-12	35	0	0	150	8202
R-HSA-73884	Base Excision Repair	0.999999999998558	-1.44147303232439e-12	35	0	0	150	8202
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.999999999998558	-1.44147303232439e-12	35	0	0	150	8202
R-HSA-162587	HIV Life Cycle	0.999999999998905	-1.09531658001695e-12	140	0	0	150	8202
R-HSA-3214858	RMTs methylate histone arginines	0.999999999998951	-1.04944748795081e-12	75	0	0	150	8202
R-HSA-73777	RNA Polymerase I Chain Elongation	0.999999999998955	-1.04474637618069e-12	88	0	0	150	8202
R-HSA-70895	Branched-chain amino acid catabolism	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-389948	PD-1 signaling	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-5627123	RHO GTPases activate PAKs	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-428930	Thromboxane signalling through TP receptor	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-112409	RAF-independent MAPK1/3 activation	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.999999999999089	-9.11148621795293e-13	23	0	0	150	8202
R-HSA-1475029	Reversible hydration of carbon dioxide	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-156581	Methylation	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-203615	eNOS activation	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-3371511	HSF1 activation	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-2022857	Keratan sulfate degradation	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-390666	Serotonin receptors	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-71384	Ethanol oxidation	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-2168880	Scavenging of heme from plasma	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-211958	Miscellaneous substrates	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-1296346	Tandem pore domain potassium channels	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-176974	Unwinding of DNA	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-417957	P2Y receptors	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-202670	ERKs are inactivated	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-166786	Creation of C4 and C2 activators	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-844456	The NLRP3 inflammasome	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-381033	ATF6-alpha activates chaperones	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-389359	CD28 dependent Vav1 pathway	0.999999999999299	-7.01427240333239e-13	12	0	0	150	8202
R-HSA-212165	Epigenetic regulation of gene expression	0.999999999999595	-4.04895746553589e-13	124	0	0	150	8202
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.999999999999865	-1.34987721013259e-13	46	0	0	150	8202
R-HSA-73776	RNA Polymerase II Promoter Escape	0.999999999999865	-1.34987721013259e-13	46	0	0	150	8202
R-HSA-112043	PLC beta mediated events	0.999999999999865	-1.34987721013259e-13	46	0	0	150	8202
R-HSA-167161	HIV Transcription Initiation	0.999999999999865	-1.34987721013259e-13	46	0	0	150	8202
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.999999999999865	-1.34987721013259e-13	46	0	0	150	8202
R-HSA-73893	DNA Damage Bypass	0.999999999999865	-1.34987721013259e-13	46	0	0	150	8202
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.999999999999865	-1.34987721013259e-13	46	0	0	150	8202
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.999999999999865	-1.34987721013259e-13	46	0	0	150	8202
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.999999999999916	-8.40467464124844e-14	54	0	0	150	8202
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.999999999999916	-8.40467464124844e-14	54	0	0	150	8202
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.999999999999916	-8.40467464124844e-14	54	0	0	150	8202
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.999999999999916	-8.40467464124844e-14	54	0	0	150	8202
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-174577	Activation of C3 and C5	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3323169	Defects in biotin (Btn) metabolism	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-199920	CREB phosphorylation	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-447038	NrCAM interactions	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-75158	TRAIL  signaling	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-166665	Terminal pathway of complement	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-429593	Inositol transporters	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-74182	Ketone body metabolism	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-5619102	SLC transporter disorders	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-448706	Interleukin-1 processing	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-427601	Multifunctional anion exchangers	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-2214320	Anchoring fibril formation	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-164843	2-LTR circle formation	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-2142789	Ubiquinol biosynthesis	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	1.00000000000053	5.30461063177627e-13	7	0	0	150	8202
R-HSA-5419276	Mitochondrial translation termination	1.00000000000056	5.55343400011602e-13	84	0	0	150	8202
R-HSA-5389840	Mitochondrial translation elongation	1.00000000000056	5.55343400011602e-13	84	0	0	150	8202
R-HSA-5368286	Mitochondrial translation initiation	1.00000000000056	5.55343400011602e-13	84	0	0	150	8202
R-HSA-453274	Mitotic G2-G2/M phases	1.00000000000115	1.15268361165851e-12	117	0	0	150	8202
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	1.00000000000144	1.44061438889056e-12	107	0	0	150	8202
R-HSA-73854	RNA Polymerase I Promoter Clearance	1.00000000000144	1.44061438889056e-12	107	0	0	150	8202
R-HSA-73857	RNA Polymerase II Transcription	1.00000000000144	1.44061438889056e-12	107	0	0	150	8202
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	1.00000000000239	2.38964422077365e-12	81	0	0	150	8202
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	1.00000000000268	2.68221286800117e-12	43	0	0	150	8202
R-HSA-1296072	Voltage gated Potassium channels	1.00000000000268	2.68221286800117e-12	43	0	0	150	8202
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	1.00000000000268	2.68221286800117e-12	43	0	0	150	8202
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	1.00000000000268	2.68221286800117e-12	43	0	0	150	8202
R-HSA-167169	HIV Transcription Elongation	1.00000000000268	2.68221286800117e-12	43	0	0	150	8202
R-HSA-72306	tRNA processing	1.00000000000286	2.85820400097443e-12	94	0	0	150	8202
R-HSA-3214815	HDACs deacetylate histones	1.00000000000286	2.85820400097443e-12	94	0	0	150	8202
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	1.00000000000327	3.27369348682295e-12	100	0	0	150	8202
R-HSA-111996	Ca-dependent events	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-157858	Gap junction trafficking and regulation	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-5656169	Termination of translesion DNA synthesis	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-174824	Lipoprotein metabolism	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-420092	Glucagon-type ligand receptors	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-2871809	FCERI mediated Ca+2 mobilization	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-68962	Activation of the pre-replicative complex	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-72086	mRNA Capping	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-420029	Tight junction interactions	1.0000000000034	3.39540769360258e-12	30	0	0	150	8202
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-5218920	VEGFR2 mediated vascular permeability	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-190828	Gap junction trafficking	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-111933	Calmodulin induced events	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-381042	PERK regulates gene expression	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-111997	CaM pathway	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-202040	G-protein activation	1.00000000000341	3.40757134915354e-12	28	0	0	150	8202
R-HSA-380108	Chemokine receptors bind chemokines	1.0000000000037	3.70465814083888e-12	56	0	0	150	8202
R-HSA-157579	Telomere Maintenance	1.00000000000378	3.77534665018145e-12	78	0	0	150	8202
R-HSA-5673000	RAF activation	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-5669034	TNFs bind their physiological receptors	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-977068	Termination of O-glycan biosynthesis	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-1296059	G protein gated Potassium channels	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-162588	Budding and maturation of HIV virion	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-1538133	G0 and Early G1	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-380994	ATF4 activates genes	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-3295583	TRP channels	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-982772	Growth hormone receptor signaling	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-2262749	Cellular response to hypoxia	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-1296041	Activation of G protein gated Potassium channels	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	1.00000000000388	3.87742596779097e-12	25	0	0	150	8202
R-HSA-391251	Protein folding	1.00000000000454	4.53796597736855e-12	55	0	0	150	8202
R-HSA-977443	GABA receptor activation	1.00000000000454	4.53796597736855e-12	55	0	0	150	8202
R-HSA-6784531	tRNA processing in the nucleus	1.00000000000454	4.53796597736855e-12	55	0	0	150	8202
R-HSA-167172	Transcription of the HIV genome	1.0000000000053	5.29959381230479e-12	67	0	0	150	8202
R-HSA-1632852	Macroautophagy	1.0000000000053	5.29959381230479e-12	67	0	0	150	8202
R-HSA-191859	snRNP Assembly	1.00000000000545	5.45491744059052e-12	50	0	0	150	8202
R-HSA-194441	Metabolism of non-coding RNA	1.00000000000545	5.45491744059052e-12	50	0	0	150	8202
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000000545	5.45491744059052e-12	50	0	0	150	8202
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000000545	5.45491744059052e-12	50	0	0	150	8202
R-HSA-427413	NoRC negatively regulates rRNA expression	1.00000000000619	6.19436474138536e-12	104	0	0	150	8202
R-HSA-112040	G-protein mediated events	1.00000000000642	6.42181149089428e-12	47	0	0	150	8202
R-HSA-73762	RNA Polymerase I Transcription Initiation	1.00000000000648	6.4840043260085e-12	48	0	0	150	8202
R-HSA-3214842	HDMs demethylate histones	1.00000000000648	6.4840043260085e-12	48	0	0	150	8202
R-HSA-3214847	HATs acetylate histones	1.00000000000752	7.52101743037954e-12	143	0	0	150	8202
R-HSA-4839726	Chromatin organization	1.00000000000767	7.66615323288842e-12	261	0	0	150	8202
R-HSA-3247509	Chromatin modifying enzymes	1.00000000000767	7.66615323288842e-12	261	0	0	150	8202
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-71262	Carnitine synthesis	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-193144	Estrogen biosynthesis	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-173736	Alternative complement activation	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-1296061	HCN channels	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-111448	Activation of NOXA and translocation to mitochondria	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-75072	mRNA Editing	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-1296053	Classical Kir channels	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-6783984	Glycine degradation	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-888593	Reuptake of GABA	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-211163	AKT-mediated inactivation of FOXO1A	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-427975	Proton/oligopeptide cotransporters	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-1369007	Mitochondrial ABC transporters	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-75896	Plasmalogen biosynthesis	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-3000497	Scavenging by Class H Receptors	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-399710	Activation of AMPA receptors	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-389599	Alpha-oxidation of phytanate	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-209905	Catecholamine biosynthesis	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-209563	Axonal growth stimulation	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-140179	Amine Oxidase reactions	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-428776	Class II GLUTs	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-165158	Activation of AKT2	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-173107	Binding and entry of HIV virion	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-75944	Transcription from mitochondrial promoters	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-139915	Activation of PUMA and translocation to mitochondria	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-442745	Activation of CaMK IV	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-1296025	ATP sensitive Potassium channels	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-390650	Histamine receptors	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-167060	NGF processing	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	1.00000000000813	8.12542055140761e-12	4	0	0	150	8202
R-HSA-111931	PKA-mediated phosphorylation of CREB	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-5656121	Translesion synthesis by POLI	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-5655862	Translesion synthesis by POLK	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-622312	Inflammasomes	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-435354	Zinc transporters	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-69205	G1/S-Specific Transcription	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-164378	PKA activation in glucagon signalling	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-174800	Chylomicron-mediated lipid transport	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-189445	Metabolism of porphyrins	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-70221	Glycogen breakdown (glycogenolysis)	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-432142	Platelet sensitization by LDL	1.00000000000922	9.21579702576524e-12	17	0	0	150	8202
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-211981	Xenobiotics	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-2024096	HS-GAG degradation	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-500657	Presynaptic function of Kainate receptors	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-379726	Mitochondrial tRNA aminoacylation	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-5621575	CD209 (DC-SIGN) signaling	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-69186	Lagging Strand Synthesis	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-198753	ERK/MAPK targets	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-156588	Glucuronidation	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-5620916	VxPx cargo-targeting to cilium	1.00000000001084	1.08444537304503e-11	21	0	0	150	8202
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-375170	CDO in myogenesis	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-1912408	Pre-NOTCH Transcription and Translation	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-5339562	Uptake and actions of bacterial toxins	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-445095	Interaction between L1 and Ankyrins	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-180786	Extension of Telomeres	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-525793	Myogenesis	1.00000000001241	1.24096906879638e-11	29	0	0	150	8202
R-HSA-381753	Olfactory Signaling Pathway	1.00000000001341	1.3414313457013e-11	381	0	0	150	8202
R-HSA-73886	Chromosome Maintenance	1.00000000001573	1.5729606628166e-11	105	0	0	150	8202
